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Adverse drug problems (ADPs) have become a serious and urgent health issue, causing 
significant morbidity, mortality, and economic burden to patients. A brief questionnaire 
asking patients how they coped with such problems can be a useful tool for providing 
timely interventions given information about their level of coping. The objective of this 
study was to develop a medication-problem coping scale to measure patients’ coping 
responses to their ADP using item response theory (IRT). 
 
Candidate items were developed based on a comprehensive literature review that 
identified relevant items for measuring how patients coped with their ADPs. To fill in 
the content gaps, new items were added to the initial item pool. The items were 
administered to patients at community pharmacies that are incorporated into the 
Minnesota practice-based research network (PBRN). Psychometric analyses based on 
IRT were performed. Items that satisfied the model assumptions and achieved an 
adequate model fit remained in the final item bank. Reliability was assessed by 
analyzing the item information and test information. Convergent validity was evaluated 
by testing a priori formulated hypotheses about expected correlations between the 
coping scores on this scale and other related scales.   
 
A total of 140 patients participated in this study by answering all items. Confirmatory 
factor analysis suggested unidimensionality of 11 items. These items demonstrated 
adequate psychometric properties when calibrated using the two-parameter logistic 
(2PL) model. Reliability was evaluated by the information of the 11-item bank and a 6-
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item short-form. Respondents reporting their ADP as relatively large showed higher 
coping scores than those who perceived their ADP as small. Health literacy levels were 
higher in patients who sought out information as a coping strategy than in those who did 
not. However, there was unexpectedly little or no relationship between patients’ coping 
levels and their coping self-efficacy.  
 
This study presents a medication-problem coping scale developed with IRT. The final 
item bank and its short-form may be applied to clinical samples to evaluate their 
usefulness.  
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Chapter 1 : INTRODUCTION 
1.1  Concern with Medication-Related Problems (MRPs) 
Medication-related problems (MRPs) have become a serious and urgent health 
problem, causing significant morbidity, mortality, and economic burden to patients. 
More than 100,000 deaths were attributed to MRPs each year, and the annual MRP-
related costs were estimated in excess of $177 billion (Ernst & Grizzle, 2001; J. A. 
Johnson & Bootman, 1995). One study indicated that MRPs accounted for 
approximately 28% of all emergency department visits, 24% of which resulted in 
hospitalization (Zed, 2005). Among MRPs, patients’ experience of adverse effects, in 
particular, have been consistently reported as one of the reasons for non-adherence to 
medication , resulting in negative health outcomes to such patients, including low 
quality of life, high risk of hospitalization, and increased healthcare costs (Ammassari et 
al., 2001; Bender & Bender, 2005; Brown, Rehmus, & Kimball, 2006; McCann, Clark, 
& Lu, 2009; McHorney, Schousboe, Cline, & Weiss, 2007; Wu et al., 2008). This 
suggests that a substantial opportunity exists for improving patients’ outcomes by 
addressing adverse drug problems (ADPs) and improving ADP management. This not 
only can help develop remedial interventions by identifying the potential causes, but 
can also reduce rates of hospitalization by improving adherence to medication or 
stopping medications that cause major problems.     
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1.2  Patients’ coping with their perceived Adverse Drug Problems (ADPs) 
As an approach for handling ADPs, asking patients directly about their ADPs is 
questionable. Physicians may avoid discussing patients’ aversions to prescribed 
medication (Britten, Stevenson, Gafaranga, Barry, & Bradley, 2004). Alternatively, a 
significant discrepancy may exist between patients’ perceived ADPs and physicians’ 
evaluations of ADPs (Larsen & Gerlach, 1996). In addition, patients sometimes 
consider their perceived ADPs are under their control and modify their treatment 
regimen independent of their physicians (e.g. they arbitrarily reduce the dosage or 
discontinue their medication to eliminate the burden from ADPs). Therefore, asking 
patients, not about the problem, but whether and how they coped with such problems 
could be more useful for gathering information about new or worsening problems that 
patients perceive after they start taking a medication and how they decide to handle 
them. Clinicians should somehow routinely ask their patients about problems related to 
their medications. 
 
1.3  Scales to measure patients’ coping with health problems 
Over the past few decades, numerous scales have been developed or applied to 
measure patients’ coping with their health-related problems. These scales include the 
Coping with Health Injuries and Problems scale (CHIP) (Endler, Parker, & 
Summerfeldt, 1998), the Coping Inventory for Stressful Situations (CISS) (Endler & 
Parker, 1990), the COPE scale (Carver, Scheier, & Weintraub, 1989) and  its brief 
version (Carver, 1997), the COping STrategies Scales (COSTS) (Beckham & Adams, 
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1984), the Coping Response Inventory (CRI) (R. Moos, 1997), the Coping Self Efficacy 
(CSE) scale (Chesney, Neilands, Chambers, Taylor, & Folkman, 2006), the Coping 
Strategy Indicator (CSI) (Amirkhan, 1990), the Ways of Coping Scale (WCS) (Lazarus 
& Folkman, 1984) and its revised version, the Revised Ways of Coping Scale (RWCS) 
(Vitaliano, Russo, Carr, Maiuro, & Becker, 1985). However, many of these scales have 
methodological weaknesses that limit their practical use (Folkman & Moskowitz, 2004; 
Parker & Endler, 1992). Information on validity and reliability of many of the scales is 
frequently limited or has not been reported; inadequate sampling of coping items and 
populations has been inherent; and the length of the scale has been potentially 
burdensome.  
In addition, these scales assess a variety of coping dimensions, although a 
specific type of coping, i.e., problem-focused coping, is more likely to be represented 
by patients who perceive ADPs from their medication. Among the various coping 
dimensions measured by the existing scales, two main coping reactions have been 
consistently reported to date: emotion-focused coping, which serves to regulate the 
negative emotions associated with the problem, and problem-focused coping, which 
aims at solving or managing the problem (Folkman & Lazarus, 1980). Examples of 
emotion-focused coping include looking on the bright side, seeking emotional support, 
having a drink or using drugs, and engaging in distracting activities. Problem-focused 
coping includes gathering information, planning, making decisions, and resolving 
conflicts. It involves instrumental, situation-specific, and task-oriented actions. In 
addition to these two coping dimensions, other coping responses, such as meaning-
focused coping, social coping, and avoidance, have been reported (Amirkhan, 1990; 
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Billings & Moos, 1981; Pearlin & Schooler, 1978). However, most attention should be 
focused on the problem-focused coping when the patient believes that he or she has the 
power to eliminate ADPs. In cases in which patients perceive ADPs while taking their 
medication, they interpret this medication as a causal factor for the ADPs, and thus they 
consider ADPs as controllable by modifying their medication use (e.g., reducing the 
dosage or discontinuing medication) (De Smedt, Haaijer-Ruskamp, Groenier, van der 
Meer, & Jaarsma, 2011). When the problem involves a controllable aspect, it generally 
calls for a greater proportion of active and instrumental problem-focused coping than 
other types of coping (Folkman & Moskowitz, 2004). For this reason, this study 
highlighted problem-focused coping rather than other types of copings. 
Notably, the existing scales are intended to measure patients’ coping with health 
problems other than ADPs. Recently, Johnson and Neilands developed a Side Effect 
Coping questionnaire (SECope) to measure patients’ coping with their HIV treatment 
side effects, and showed its reliability (internal consistency and test-retest) and 
construct and criterion validity (M. O. Johnson & Neilands, 2007). By adding two items 
to the SECope scale, De Smedt et al. also used this slightly revised version to assess 
coping with adverse drug events in patients with heart failure (De Smedt, Haaijer-
Ruskamp, Groenier, van der Meer, & Jaarsma, 2011). The samples in these studies, 
however, were limited to patients with HIV and HF, although coping items in the 
SECope are applicable to patients with other medical conditions. Moreover, there was a 
lack of information on how precisely each item measures across the full spectrum of 
patient’s coping with ADPs. In other words, the relationship between a patient’s coping 
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level and the probability of endorsing the individual item was not examined in the 
studies.  
 
1.4  Use of Item Response Theory (IRT) in health outcomes research  
A novel technique, item response theory (IRT), has been increasingly applied in 
developing and assessing health-related outcome measures over the past few years. This 
theory compensates for several limitations that classical test theory (CTT) possesses, 
including sample-dependent item- and scale- statistics, and unreasonable assumptions 
such as item equivalence and  identical measurement errors over all of the scores (De 
Champlain, 2010). In addition, the IRT model can allow us to measure the latent trait 
more precisely by yielding the most information from each patient; it relates item 
characteristics and patient characteristics to the probability of a positive response. 
Moreover, it can improve efficiency by minimizing the number of items 
required to obtain a desired degree of precision without compromising reliability. It also 
enables optional use of interchangeable items. For these reasons, the National Institutes 
of Health have undertaken a major initiative to develop standardized and well-calibrated 
measures of patient-reported outcomes using IRT since 2004. In particular, the use of 
IRT models has grown considerably in such areas as physical function (Fries, Bruce, 
Bjorner, & Rose, 2006; Rose, Bjorner, Becker, Fries, & Ware, 2008), asthma (Yeatts et 
al., 2010), COPD (Choi, Victorson, Yount, Anton, & Cella, 2011), fatigue in cancer 
(Garcia et al., 2007), sleep disturbance (Buysse et al., 2010), depression (Gibbons et al., 
2011), and anxiety (Becker et al., 2008). This study is the first to use IRT to assess 
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1.5  Objectives and aims 
The objective of this study was to develop a reliable and valid patient-reported 
ADP coping scale. Asking patients about their level of coping with perceived ADPs, 
clinicians can provide interventions tailored to the individual, which represents an 
efficient and economical way to discuss and resolve ADPs. By improving ADP 
management, patients can achieve safer and more effective medication use.  
To achieve the objective, this study had the following specific aims: 
Aim 1: To construct an item pool to evaluate patients’ coping with their perceived 
ADP.  
Candidate items were identified from the existing coping scales by conducting a 
comprehensive literature review. The content relevance of each item was assessed to 
decide whether it should be considered for a new scale. Items were considered to be 
included in the new scale if they measure patients’ behaviors that respond to their 
perceived ADP aiming to solve or manage the problem. (A latent variable defined in 
this study is detailed in chapter 2.) In addition, new items were created to fill in the 
content gaps. The constructed item pool was expected to cover the whole range of 
patients’ ways of coping. The developed items were then administered to patients who 
perceive an ADP. 
  
Aim 2: To conduct psychometric analyses based on item response theory (IRT). 
To create the final item bank, psychometric analyses were conducted. The 
analyses included evaluating the assumptions of the IRT model, estimating item 
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parameters, and assessing the model fit to the data. Items that satisfied the model 
assumptions and achieved an adequate model fit remained in the final item bank. 
 
Aim 3: To assess reliability and construct validity of the constructed scale. 
To assess precision at the item level, the item information function (IIF) was 
examined for each individual item. At the scale level, the test information (the sum of 
each item’s information), was analyzed to examine the reliability of the scale as a set of 
items. To assess convergent validity, a priori formulated hypotheses about expected 
correlations between the coping scores on the new scale and other related scales were 
tested. These other related scales included a problem scale, a health literacy scale, and 
the problem-focused subscale of coping self-efficacy (CSE). Positive relationships 
between scores on the coping level and scores from these scales were hypothesized.  
 
1.6  Significance of the study 
In this study, data were directly from patients who experience an ADP, and not 
from their providers. Typically, clinical measures by healthcare providers are narrowly 
focused and assess physiological, biomedical, and/or limited functional dimensions of 
an ADP.  Sometimes providers are not even aware of their patients’ perceived ADP. In 
contrast, patient-reported measures capture problems as perceived by patients that affect 
their medication-taking behavior (Barr, 1995). Notably, outcomes important to patients 
are influenced not just by clinical indicators but also by a complex interaction of 
physical, social, and psychological factors (Chang et al., 2011). Patients’ self-reports are 
particularly important when they do not correspond to those drawn from clinical 
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measures. Clinicians may concentrate more on the severe side effects that impact 
directly on morbidity or mortality, whereas patients may also attend to mild, but 
bothersome side effects (Larsen & Gerlach, 1996).  
Use of patient-reported outcomes (PROs) reflect patients’ changing role with 
regard to the care they receive and their increased participation in the health-related 
decision-making process. In other words, self-reported measures can facilitate a patient-
centered care. Over the past few decades, patients have become active players in the 
healthcare process, shifting away from passive recipients of treatment, and they have 
become more actively engaged in the decision-making process (Linacre, 1994; 
Meadows, 2011). In accordance with this trend, PROs have gained increasing 
prominence, which is reflected in recent national policy and initiatives in the U.K. 
(Darzi, 2008). For example, since April 1st, 2009, NHS-funded hospitals have been 
required to ask patients to complete a PRO-measures questionnaire before and after four 
surgical procedures defined by the NHS (Palfreyman, 2011). Likewise, the National 
Institutes of Health in the U.S. have undertaken a major initiative to develop 
standardized and well-calibrated measures of PROs since 2004. The U.S. Food and 
Drug Administration (FDA) has also recognized the growing value of PROs and 
responded by publishing guidelines on the use of PRO measures in medical product 
development in 2006 (the draft version) and 2009 (the revised version). These 
guidelines confirm the expanded role of PROs in the drug approval process. All of these 
suggest that the influence of patients’ perspectives in health-related decisions will grow 
in importance throughout the process of providing care.  
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The importance of using a patient-reported measure becomes greater when 
addressing a patient’s perception of an ADP and assessing his or her coping behaviors. 
Previous evidence suggests that between one-third and one-half of patients do not 
spontaneously report ADPs or ADP-related modifications they made to their treatment 
regimen to their healthcare providers (Jarernsiripornkul, Krska, Capps, Richards, & 
Lee, 2002; Pound et al., 2005). This may lead to suboptimal medication use and more 
severe morbidity and mortality later; therefore, a patient’s perceived ADP and his or her 
responses should be ascertained. Using a self-report measure, providers can identify 
how patients have coped with an ADP and provide timely interventions to such patients. 
Also, by applying this measure as a screening device for clinical assessments of ADPs 
to busy clinical settings, practitioners can save their time. After receiving practitioners’ 
timely assistance with an ADP, patients can optimize their medication use.   
 
1.7  Contribution to the field 
The developed item set can be used by clinicians to receive their patients’ 
feedback on coping with a perceived ADP. Since this item set is brief and easy to 
administer, clinicians can find their patients’ ADP immediately and provide timely 
interventions tailored to the individual without imposing heavy burdens to them. This 
could be an efficient and economical way to discuss and resolve ADPs. By improving 
ADP management, patients can achieve safer and perhaps more effective medication 
use. This can contribute to reducing healthcare expenditures, which have been 
increasing dramatically in recent decades, by preventing potential morbidity and 
mortality from the ignored ADPs. 
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Chapter 2 : LITERATURE REVIEW 
This chapter reviews the literature on the measures of patients’ coping with their 
perceived health-related problems, and provides the theoretical framework of this study. 
The electronic databases Pubmed® (1950 through January 2012) and PsycINFO® (1806 
through January 2012) were searched using a keyword “coping” in combination with 
“adverse drug problem” and its synonyms (e.g., side effect*, adverse drug event*, 
adverse drug reaction*, adverse effect*, medication (related) problem*, and drug therapy 
(related) problem*) and “scale” and its synonyms (e.g., questionnaire* and instrument*). 
This resulted in about 34,400 articles, and articles were reviewed if they involved a 
development or evaluation of the coping behaviors to health-related problems.   
  
2.1  Measures of coping in response to health-related problems 
Ways of Coping Scale (WCS) and its revised version (RWCS): 66 items (Lazarus & 
Folkman, 1984) and 42 items (Vitaliano, Russo, Carr, Maiuro, & Becker, 1985) 
The original form of the WCS was designed to measure an individual’s constantly 
changing cognitive and behavioral efforts to manage the internal and/or external demands 
of particular stressful situations. The authors conceptualized coping as a dynamic process 
in which a person employs different forms of coping depending on the status of the 
person-environment relationship. Therefore, it intends to measure coping as a dynamic 
process, not as coping style or trait. After conducting a factor analysis with 42 items from 
the pool of 66 items, the authors identified eight subscales (one problem-focused and 
seven emotion-focused), which were labeled as problem-focused coping, wishful 
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thinking, detachment, seeking social support, focusing on the positive, self-blame, 
tension-reduction, and keep to self (Folkman & Lazarus, 1985). However, a study using a 
different 50-item subset identified slightly different eight subscales which were 
conceptualized as confrontive coping, planful problem-solving, distancing, self-
controlling, seeking social support, accepting responsibility, escape avoidance, and 
positive appraisal. The first two subscales measure problem-focused coping, while the 
other six measure emotion-focused coping strategies (Folkman, Lazarus, Dunkel-
Schetter, DeLongis, & Gruen, 1986). The WCS was then revised by eliminating the 
redundant items, rewording the unclear items, and adding several items. The response 
options were also changed from a dichotomized format (Yes/No) in the original version 
to a 4-point scale (0 = does not apply and/or not used; 3 = used a great deal) in the 
revised version. The revised version had five subscales: problem-focused coping (15 
items), blaming self (3 items), wishful thinking (8 items), seeking social support (6 
items), and avoidance (10 items). There was evidence to support the internal consistency 
of the WCS and RWCS (Cronbach alphas ranging from 0.61 to 0.79 and from 0.77 to 
0.83, respectively). Construct validity was assessed by examining correlations between 
the various subscales of RWCS and persons’ responses to the stressors such as anxiety 
and depression (Vitaliano, Russo, Carr, Maiuro, & Becker, 1985). Depression was 
negatively related to the problem-focused coping and positively related to wishful 
thinking. Also, medical students in group therapy were shown to receive significantly 
higher scores than students not having such therapies.  
Respondents are asked to indicate to what extent they employed each coping 
strategy presented in the RWCS using a 4-point scale, ranging from 0 = not used to 3 = 
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used a great deal. Sample items include, “talked to someone to find out more about the 
situation,” “made a plan of action and followed it,” and “just concentrated on what I had 
to do next.”  
 
Medical Coping Modes Questionnaire (MCMQ) and its revised version: 19 items (Feifel, 
Strack, & Nagy, 1987a) and 20 items (Feifel, Strack, & Nagy, 1987b) 
The MCMQ was designed to assess coping with illnesses. This was particularly 
developed for use in medical settings and items focused on coping responses to a current 
illness. It provides scores on three subscales: confrontation with eight items, avoidance 
with seven items, and acceptance-resignation with four items. The MCMQ had evidence 
of internal consistency (Cronbach alphas ranging from 0.66 to 0.70). In those subscales, 
acceptance-resignation was a particularly manifest coping strategy employed by patients 
with little expectation of recovery and a lack of hope. Coping strategies such as 
avoidance and acceptance-resignation were negatively associated with effectiveness of 
coping assessed by their physicians and significant others (e.g., wives). To investigate the 
coping strategies employed by patients confronting different conditions, patients with 
life-threatening illnesses (e.g., cancer, heart disease) were compared to those with 
nonlife-threatening illnesses (e.g., arthritis, orthopedic low back pain, dermatitis). Results 
showed that patients with life-threatening illnesses employed more confrontation coping 
than nonlife-threatened patients. However, there was no significant difference for the 
avoidance and acceptance-resignation coping scales between them. The scale developer 
revised the original MCMQ version based on factor analyses of an item pool that they 
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generated. The revised version, MCMQ-R, consists of 20 items, grouped into four 
subscales: information seeking, social support seeking, avoidance, and resignation. 
Respondents are asked to indicate how often they use each coping strategy 
presented in the MCMQ-R using a 5-point scale, ranging from never to always. Sample 
items include, “I have asked my doctor questions about my illness” (information seeking) 
and “I try to talk about my illness with my friends or relatives” (social support seeking).  
 
Coping Responses Inventory (CRI): 48 items (R. Moos, 1993; R. H. Moos, 1988) 
The CRI was developed to identify the cognitive and behavioral responses 
employed to cope with a recent problem or stressful situation. It consisted of 48 items 
grouped into two subscales (approach coping and avoidance coping). Each subscale was 
then divided further into two cognitive coping subdomains and two behavioral coping 
subdomains. That is, approach coping consisted of four subdomains such as logical 
analysis, positive appraisal, guidance/support, and problem solving; avoidance coping 
was composed of cognitive avoidance, resigned acceptance, alternative rewards, and 
emotional discharge. The first two subdomains in each subscale reflected cognitive 
coping, while the last two subdomains reflected behavioral coping. All eight subdomains 
showed internal consistencies with Cronbach alphas ranging from 0.58 to 0.74. The 
authors assessed convergent validity by means of correlations with previous versions of 
the test. Results showed that the correlation coefficients varied from 0.56 (emotional 
discharge) to 0.95 (seeking guidance and support) between these conceptually 
comparable scales.  
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Separate versions of the CRI have been developed for adults (older than 18 years 
of age) and for youth (ages between 12 and 18). Respondents indicate how often they 
used various coping strategies to deal with the most important problem they faced during 
the past year on a 4-point scale from not at all to fairly often. Sample items include, “talk 
with a professional person,” “try to find out more about the situation,” and “try to learn to 
do more things on your own.” 
 
COPE and its brief version: 60 items (Carver, Scheier, & Weintraub, 1989) and 28 items 
(Carver, 1997) 
The original COPE inventory was developed to measure different ways in which 
people respond to stress. In developing the COPE, the authors used Lazarus’ transactional 
stress model which was used for the development of the WCS, but they also used a self-
regulatory model as a theoretical framework. There were 13 subscales defined in the 
original COPE, each with a specific conceptual focus: five subscales (active coping, 
planning, suppression of competitive activities, restraint coping, and seeking of 
instrumental social support) incorporate problem-focused coping, while another five 
subscales (seeking of emotional social support, positive reinterpretation, acceptance, 
denial, and turning to religion) measure emotion-focused coping. The other three 
subscales (focus on and venting of emotions, behavioral disengagement, and mental 
disengagement) measure coping responses that arguably were less useful. Its brief 
version, the Brief COPE (BCOPE), had three subscales (i.e., dysfunctional coping, 
problem-focused coping, and emotion-focused coping) with 28 items. The dysfunctional 
coping strategy includes coping reactions such as behavioral disengagement, self-
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distraction, self-blame, substance use, and venting; the problem-focused coping 
incorporates active coping, instrumental support, and planning, while emotional-focused 
coping includes acceptance, emotional support, humor, positive reframing, religion, and 
denial. Although internal consistency varied with Cronbach alphas ranging from 0.50 to 
0.90 across all subscales (Carver, Scheier, & Weintraub, 1989), it was adequate for some 
subscales such as emotion-focused, problem-focused, and dysfunctional coping with 
alpha values of 0.72, 0.84, and 0.75, respectively (Cooper, Katona, & Livingston, 2008). 
There was evidence of convergent and concurrent validity by showing that the subscales 
were predicted by secure attachment, burden, avoidant attachment, and social support 
(Cooper, Katona, & Livingston, 2008). 
Respondents are asked to rate their degree of agreement with each statement on a 
4-point scale, ranging from 0 (“I haven’t been doing this at all”) to 3 (“I’ve been doing 
this a lot”). Sample items include, “I take additional action to try to get rid of the 
problem,” “I take direct action to get around the problem,” and “I ask people who have 
had similar experiences what they did.” 
  
Coping Inventory for Stressful Situation (CISS): 48 items (Endler & Parker, 1990)  
The CISS was derived from its earlier version, the Multidimensional Coping 
Inventory (MCI). After a series of factor analyses, the MCI has been revised and renamed 
as the CISS. The CISS was developed to be used for determining an individual’s 
preferred coping style and contributing to understanding of the differential relationship 
between coping style and other personality variables. It measures three subscales which 
assess task- , emotion-, and avoidance-oriented coping. The avoidance subscale is divided 
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further into two separate domains assessing avoidance through social interaction and 
avoidance based on distraction. The authors argued that the alpha coefficients were 
highly satisfactory across the normative groups. Test-retest reliabilities were moderate to 
high: coefficients for the task- and emotion-oriented coping subscales were equal to or 
greater than 0.68. The avoidance-oriented coping and its two subdomains had limited 
reliabilities ranging from 0.51 to 0.60. Construct validity was supported by negative 
relationships between task-oriented coping and depression (Mitchell & Hodson, 1983). 
Also, numerous studies showed that emotion-oriented coping was employed more 
frequently in individuals with depression compared to non-depressed individuals 
(Billings, Cronkite, & Moos, 1983; Billings & Moos, 1984; Mitchell, Cronkite, & Moos, 
1983). A more recent study showed that depressive symptoms and anxiety levels were 
positively associated with emotion-oriented coping and negatively with task-oriented 
coping (McWilliams, Cox, & Enns, 2003).  
Respondents are asked to rate how much they engage in each activity when they 
encounter a difficult, stressful, or upsetting situation using a 5 point Likert scale ranging 
from 1 (not at all) to 5 (very much). Sample items include, “think about how I have 
solved similar problems,” “consider different solutions to the problem,” and “decide 
course of action.” 
 
Coping Strategy Indicator (CSI): 33 items (Amirkhan, 1990) 
The CSI is distinct in that it combined both inductive and deductive 
methodologies when it was developed. That is, the developer first derived 161 coping 
responses from existing scales and from his previous research, and then reduced items by 
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conducting a series of factor analyses with independent large samples. The final version 
of CSI consisted of three subscales (problem solving, seeking support, and avoidance), 
each with 11 items. The scale measures coping strategies employed in response to a 
worrisome problem that was experienced within the last six months. Three subscales 
showed adequate internal consistency with Cronbach alphas ranging from 0.84 to 0.93. 
Tests of convergent validity showed that the CSI and WCS were moderately but 
significantly correlated. The CSI was shown to be resistant to social desirability biases. 
Respondents are asked to indicate the extent to which they engaged in each of 33 
coping strategies using a 3-point scale (not at all, a little, or a lot). Sample items include, 
“tried to solve the problem,” “brainstormed all possible solutions before deciding what to 
do,” and “set some goals for yourself to deal with the situation.” 
 
Coping with Health Injuries and Problems (CHIP): 32 items (Endler, Parker, & 
Summerfeldt, 1998) 
The CHIP scale was designed to measure coping reactions to health problems. 
Coping was defined as cognitive and behavioral attempts to change, modify, or regulate 
internal or external factors which may be adaptive or maladaptive, and health problems 
were defined as a specific type of stressors that may vary according to duration, degree of 
chronicity, or amount of personal control. Factor analyses supported its 4-factor structure 
(distraction, palliative, instrumental, and emotional preoccupation), each with 8 items: 
distraction coping represents the extent to which the person uses action and cognitions 
that are aimed at avoiding preoccupation with the health problem; palliative coping 
involves a variety of self-help responses aimed at alleviating the unpleasantness of the 
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situation; instrumental coping involves task-oriented responses such as actively seeking 
out health information or seeking medical advice; and emotional preoccupation coping 
involves fixation with the emotional consequences of the health problem. The CHIP 
subscales had evidence of adequate internal consistency in adults, general medical 
patients, and patients with lower back pain (Cronbach alphas ranging from 0.70 to 0.88). 
Preliminary validity was suggested by comparing CHIP scores with basic coping styles 
and by comparing the coping behaviors of patients with acute and chronic illnesses. 
Respondents indicate the frequency in which they were involved in 32 specific 
coping responses on a five-point scale, ranging from 1 = not at all to 5 = very much. In 
addition to these 32 items, they are asked about the name of the illness, a rating of 
severity of the illness, and the actual duration of the illness. The scale is copyrighted by 
Multi-Health Systems.  
 
Coping Self-efficacy (CSE): 26 items (Chesney, Neilands, Chambers, Taylor, & 
Folkman, 2006)  
The CSE scale was designed to measure individuals’ evaluations of their self-
efficacy for coping with challenges or threats. It particularly focuses on changes in an 
individual’s confidence in his or her ability to cope, which results in the individual’s 
changing coping behavior according to self-efficacy theory (Bandura, 1977). The scale 
items were developed based on stress and coping theory and the ways of coping scale. 
The CSE consisted of 13 items grouped into three subscales: problem-focused coping (6 
items), emotional-focused coping (4 items), and support from friends and family (3 
items). There was evidence of the internal consistency of the CSE subscales (Cronbach 
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alphas ranging from 0.80 to 0.91). Predictive validity was assessed by showing that 
problem- and emotional-focused coping were predictive of reduced psychological 
distress and increased psychological well-being over time.  
Respondents are asked, “when things aren’t going well for you, or when you’re 
having problems, how confident or certain are you that you can do the following,” and 
then asked to rate on an 11-point scale the extent to which they believe they could 
perform behaviors important to adaptive coping (e.g., “sort out what can be changed, and 
what cannot be changed”, “break an upsetting problem down into smaller parts”, “look 
for something good in a negative situation”, and “get emotional support from friends and 
family”). Anchor points on the scale were 0 (“cannot do at all”), 5 (“moderately certain 
can do”) and 10 (“certain can do”). 
 
Side Effect Coping Questionnaire (SECope): 20 items (M. O. Johnson & Neilands, 2007) 
Recently, the SECope was developed to measure patients’ coping with HIV 
treatment side effects. Although items were developed through qualitative interviews 
with persons who reported side effects from their HIV treatment, they were applicable to 
patients with other medical conditions. De Smedt et al., applied the SECope to patients 
with heart failure after adding two items based on their pilot cognitive interviews with 
seven patients (De Smedt et al., 2012). After conducting factor analysis, authors 
identified five subscales such as positive emotion focused coping, social support seeking, 
nonadherence, information seeking, and taking another medication to ameliorate the side 
effect. Internal consistency for the global SECope was assessed with a coefficient value 
of 0.87. Construct and criterion validity were supported by correlations between the 
   
20 
 
subscales and other construct measures. For example, there was association between the 
nonadherence subscale and poor provider relations, low treatment knowledge, and high 
beliefs of treatment effectiveness.  
Respondents are asked to indicate how often they used each coping strategy on a 
5-point scale from 0 = never to 4 = very often. Sample items include, “think about good 
times in the past” (positive emotion focused coping), “reduce the dose of the medication 
that is causing the side effect” (nonadherence), and “take a medication that will make the 
side effect feel better or go away” (taking side effect medications).  
 
The scales are listed above if they intend to measure patients’ coping with their 
stressors including their general health-related problems. The scales measuring with the 
presence and or intensity of particular side effects of specific medications (e.g., 
anticancer medications, antipsychotics, or antiepileptics) are not discussed here because 
they were applicable only to patients with such diseases. These types of measures are 
briefly summarized in Table 2-1. 
 
2.2  Summary of the literature review 
As consistently reported in the coping literature, all scales in this review included 
at least two major types of coping, i.e., problem-focused coping and emotion-focused 
coping. Since this study emphasizes problem-focused coping with the reason noted 
earlier, the problem-focused coping items were examined cautiously. Of the scales, the 
SECope was particularly relevant to our study in that this questionnaire asked about 
patients’ coping with specific side effects other than their coping responses to an ongoing 
illness or the general health problem which other scales asked about. The contents of the 
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items asking about coping responses to an ongoing illness or the general health problem 
seem to be too broad to be adopted for a new scale. However, the SECope included items 
applicable to a new scale, including “decide that the medication is not worth the side 
effect and stop taking it,” “reduce the dose of the medication that is causing the side 
effect,” “take less of the medication to see if the side effect is not so bad (smaller doses or 
less frequent),” “talk to your doctor or health care provider about the problem,” “try to 
get more information about the medication or side effect,” “take another medication to 
deal with the side effect,” “take a medication that will make the side effect feel better or 
go away,” “request a medication from your doctor to help the side effect,” and “talk to 
family, friends, loved ones about the problem.” These nine items were incorporated in the 
subscales such as nonadherence, information seeking, taking another medication to 
ameliorate the side effect, and social support seeking, but not in the positive emotion-














Table 2-1. Scales to measure coping with side effects of specific medicationsa,b 
Name Purpose Domains Number 
of items 
ASC-SR: Approaches to Schizophrenia 
Communication- Self-Report checklist 
To measure antipsychotic drug side effects for use in clinical practice n/r 17 
C-PET: Clinical checklist for Patients with 
Endocrine Therapy 
To measure occurrence of side effects associated with hormonal treatment 
of breast cancer  
n/r 13 
C-SAS: Chemotherapy Symptom Assessment 
Scale 
To document side effects of chemotherapy n/r 24 
GASS: Glasgow Antipsychotic Side-effect Scale To detect side effects of second generation antipsychotics 9 domains (sedation and CNS; 
cardiovascular; extrapyramidal; 
anticholinergic; GI; genitourinary; 
screening for DM; prolactinaemic; 
weight gain) 
21 
ICQ: Inhaled Corticosteroid Questionnaire To measure patient-perceived side effects of inhaled corticosteroid 15 domains (voice problems; 
oropharynx problems; unpleasant taste; 
skin, hair, and nails; mood problems; 
taste disruption; perspiration; 
oropharyngeal itching; thirst; tiredness; 
oral candidiasis; facial edema; vision 
deterioration; dental deterioration; eye 
dryness) 
57 
LUNSERS: Liverpool University Neuroleptic Side 
Effect Rating Scale  
To measure side effects of neuroleptic drugs n/r 41 



















skin; urinary; whole body) 
73 
MPQ: Medication Problems Questionnaire To measure self-rated side effects of interferon drugs n/r 21 
MSEC: Medication Side Effect Checklist To assess the severity of analgesic side effects n/r 6 
MTSOSD: Modified Transplant Symptom 
Occurrence and Symptom Distress  
To assess symptom frequency and distress associated with triple drug 
therapy after transplantation 
n/r 29 
PNS: Peripheral Neuropathy Scale (aka 
FACT/GOG-Ntx subscale) 
To measure peripheral neuropathy associated with chemotherapy 2 domains (hand neuropathy, foot 
neuropathy) and 2 items not included 
in domains 
11 
SEALS: Side Effect and Life Satisfaction To measure subjective side effects of anti-epileptic medication 5 domains (cognition; dysphoria; 
temper; tiredness; worry) 
38 
SES-HP: Side effect scoring system for 
helicobacter pylori treatment regimens 
To measure side effects of helicobacter pylori treatment regimens n/r 9 
UKU: Udvalg for Kliniske Undersogelse To measure side effects of psychotropic drugs 4 domains (Psychic functions; 
neurological signs; autonomous side 
effects; other side effects) 
48 
WCQ: Worthing Chemotherapy Questionnaire  To document side effects of chemotherapy 6 domains (digestive system; mouth 
and nose; skin and hair; eyes; general 
physical health; moods and feelings) 
75 
a
 Adding several scales to the scales reported by Foster et al.’s study (Foster, van der Molen, Caeser, & Hannaford, 2008) 
b
 Scales assessing only one individual symptom as an adverse event (e.g., tardive dyskinesia) were excluded. These scales include Abnormal Involuntary Movement 
Scale (AIMS), Akathisia Ratings of Movement Scale (ARMS), Barnes Akathisia Rating Scale (BARS), Dyskinesia Identification System Condensed User Scale 
(DISCUS), Extrapyramidal Symptom Rating Scale (ESRS), Hillside Akathisia Scale (HAS), Neurological Rating Scale (aka SimpsonAngus Scale (SAS)), Tardive 
Dyskinesia Rating Scale (TDRS), Texas Research Institute for Mental Sciences Tardive Dyskinesia Scale (TRIMS), and Withdrawal Emergent Symptoms Checklist 
(WES). 
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2.3  Theoretical framework 
Self-Regulatory Model (SRM) 
Leventhal et al. developed the common sense model of self-regulation to 
understand how people adapt to and manage specific health threats (Leventhal, 
Diefenbach, & Leventhal, 1992) (Figure 2-1). More specifically, these authors tried to 
identify individual’s reactions during threat episodes to describe how the emotional 
process interacts with illness representations, and to explain the individual’s processes 
for coping and appraising the outcomes of their attempts to self-regulate. In this 
theoretical model, an individual tries to make sense of a health threat such as a 
perceived ADP by developing emotional representations about the threat; the individual 
then uses these representations to guide his or her behavior to close the gap between 
current health status and desired health status. Thus, there are two underlying processes 
active in an individual who faces a health threat: the emotional representations and 
cognitive interpretation of the threat. Both of these perceptions give guidance for 
patients’ coping behavior and appraisal of their management of the health threat.  
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In recent years, the Illness Perception Questionnaire (IPQ), a measure based on 
the SRM, has been used to measure illness perceptions (Kaptein et al., 2007). This 
questionnaire includes five domains and was extended with two more domains; it has 
been renamed as the Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et 
al., 2002). More specifically, the revised version incorporated the subscales to assess 
emotional representations (e.g., anxiety and anger) and to assess the extent to which the 
illness makes sense to the individual. 
The SRM can be useful in understanding how individuals formulate their 
appraisal of health threats such as an adverse problem from a medication. For this 
reason, this model has often been adopted to outline the perceptions of patients with 
schizophrenia (i.e., severe mental health difficulties) (Lobban, Barrowclough, & Jones, 
2004; Lobban, Barrowclough, & Jones, 2005) and various chronic diseases (e.g., 
cardiac diseases) (Grace et al., 2005; Hirani, Pugsley, & Newman, 2006; Lane, 
Langman, Lip, & Nouwen, 2009). In particular, an ADP, like an illness, can be 

















Internal and external stimuli generate a cognitive interpretation of the threat and the emotional 
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perceived as a health threat; therefore, this model was also applied to outline patients’ 
perception of ADPs in HIV (M. O. Johnson & Folkman, 2004) and HF (De Smedt, 
Haaijer-Ruskamp, Groenier, van der Meer, & Jaarsma, 2011).  
The SRM guides this study since patients’ handling of an ADP could be 
informed by the theoretical understanding of illness representation and coping, and 
outcome appraisal. 
 
2.4  Operational definition of coping  
According to the self-regulatory model, an individual encountering a stressor 
develops an emotional representation and interprets the contextual meaning of the 
stressor to proceed to the next underlying stages: coping procedures and appraisal. 
Appraisal refers to an individual’s evaluation of the success or failure of the coping 
procedure. Coping procedure refers to an individual’s behavioral or cognitive efforts to 
manage the stressor, and has two manifest types: active behavior (problem-focused) and 
regulation of distress (emotion-focused). Since this study highlighted problem-focused 
coping rather than emotional-focused coping for the reason noted earlier, a scale was 
developed focusing on behavioral aspects of coping rather than affective or cognitive 
coping. Patients’ coping behaviors are thought to be most directly related to the effects 
of a perceived ADP on medication use, hence safety and effectiveness. Therefore, the 
definition of “coping” in this study is as a set of patient behaviors that respond to 
patients’ perceptions of adverse drug problems, aiming to solve or manage the problem. 
A bank of questions (items) was developed to operationalize this definition and measure 
how patients cope with perceived ADPs.  
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Chapter 3 : RESEARCH METHODS 
3.1  Selection of items 
The content of the medication-problem coping scale (MPCS) was mostly based 
on the SECpoe questionnaire. Nine items in the MPCS were adopted from the SECope 
four subscales – nonadherence, information seeking, taking side effect medications, and 
seeking social support. Items in the positive emotion-focused coping subscale of the 
SECope were not included in the MPCS because this study highlighted problem-
focused coping rather than emotional-focused coping for the reason noted previously. 
However, all adopted items were reworded, and the response options were changed 
from a 5-point scale to a dichotomous format (yes/no) in the MPCS because several 
items could not be answered using a polychotomous format (e.g., entirely stopped using 
the medication, continued to use the medication as prescribed in spite of the problem, 
got admitted to the hospital). Fourteen items were then added to the MPCS to fill in the 
content gaps. These items were 
• tried to learn more about whether the problem was related to my 
medication 
• continued to use the medication as prescribed in spite of the problem 
• visited my physician or nurse to resolve the problem 
• asked my physician or nurse to prescribe a different medication 
• limited my activities or changed my daily routines 
• sought out information that would help me resolve the problem 
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• tried to see if other people like me experienced the same problem I had 
• took seek time or worked less than usual 
• visited my pharmacist to resolve the problem 
• used home remedy to treat the problem 
• visited an emergency department or went to urgent care 
• got admitted to the hospital 
• used a non-prescription medication instead of using the medication 
• used home remedy instead of using the medication. 
The items were then reviewed by four pharmacy faculty, one medicine faculty, 
one clinical psychologist, and were modified according to their feedback. A total of 23 
items were retained in the initial item pool and a pretest of the draft questionnaire was 
conducted with four subjects before administering it to patients in the field.  
 
3.2  Study design 
Data on coping behaviors were collected from patients in community 
pharmacies with a health-related problem that they attributed to their medication use. 
These community pharmacies are incorporated into the Minnesota Practice-Based 
Research Network (MN PBRN), an organization that combines community pharmacies 
with University faculty and a professional organization to help address societal, 
community, or professional questions related to medication use. For recruiting 
pharmacies to help our data collection from their patients, an email introducing the 
study (Appendix D) was sent to MN PBRN pharmacies. The email included our contact 
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information for pharmacists who wanted to participate in this study. Because there was 
no response from these pharmacists for two weeks after sending this email, three 
pharmacies (PRO pharmacy, Watertown pharmacy, and Setzer pharmacy) were directly 
contacted and asked permission to recruit patients in their practice sites after providing 
study objectives and a data collection plan. Since three pharmacies all allowed me to 
approach patients in their practice sites, patients waiting for their prescribed 
medication(s) in their sites were potential participants in the study. These patients were 
first asked about their willingness to participate in the study (Recruitment script is 
shown in Appendix E). If patients agreed to be involved in the study, they received a 
questionnaire completed with my assistance in answering the questions. The 
questionnaire consists of a few basic questions asking about number of medications 
being taken, purpose of taking medication(s), and whether they experienced medication-
related ADP(s) during the past one year. If they had any perceived medication-related 
ADP(s), they were asked about medication to which they attribute their ADP, and 
whether they employed a coping response to their ADP, each presented by a separate 
item using a ‘yes/no’ response format. If patients experienced more than one ADP, they 
were asked to select the most bothersome ADP. The questions asking about an ADP-
related medication and coping responses to ADP were not applicable to patients who 
did not experience medication-related ADP(s). However, demographic information was 
collected among patients who had not experienced ADP(s) but agreed to provide such 
information.  
Because there was no precise rule to calculate sample size for IRT analyses, 
sample size in this study was consistent with general guidelines based on reported 
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experience and simulation studies. For the Rasch model, Linacre (1994) and Wright and 
Tennant (1996) recommended at least 30 responders to have 95% confidence that no 
item calibration parameter is more than 1 logit from its stable value; and about 100 
subjects for 1/2 logit (Linacre, 1994; Wright & Tennant, 1996).  Streiner and Norman 
(2008) also suggested 30 subjects as the minimum requirement for a one-parameter 
model with a dichotomous response option (Streiner & Norman, 2008). However, the 
sample size requirement should increase as the number of parameters increases. 
Therefore, the minimum number of respondents were determined as 100 for IRT 
analyses in this study.  
 
3.3  Psychometric analyses 
Evaluation of the assumptions of the IRT model 
IRT entails three assumptions: unidimensionality of the latent trait, local 
independence of items, and monotonicity of the scale. Unidimensionality means that the 
scale is measuring only one latent trait (i.e., a level of coping behaviors to perceived 
ADP in this study); Local independence means that, conditioning on the latent trait 
being measured, the probability of endorsing a specific item is unrelated to the 
probability of answering any other item. That is, only the latent trait influences the 
probability of endorsing an item; Monotonicity means that the probability of endorsing 
a given item should increase monotonically with higher scores on the scale.   
To investigate the dimensionality of the item set, confirmatory factor analysis 
(CFA) was conducted based on non-linear model using Mplus 6.1 in this study. The 
following fit criteria were used to determine whether items were unidimensional: the 
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Tucker-Lewis Index (TLI), the Comparative Fit Index (CFI), or the Root Mean Square 
Error of Approximation (RMSEA). The value of TLI and CFI > 0.90 and RMSEA < 
0.10 were suggested to indicate reasonable fit (Browne & Cudeck, 1993). Local 
independence was evaluated by examining Chen & Thissen’s LD X2 statistic, computed 
by comparing the observed and expected frequencies between responses to each item 
and each of the other items, i.e. the association or correlation between items. Large 
values of standardized X2 indicate a potential violation of local independence. Finally, 
item characteristic curves (ICCs) were investigated for each item to assess whether the 
probability of endorsing an item consistently increased as the level of the latent trait 
increased.  
 
Estimating item parameters: Marginal maximum likelihood method (Bock & Aitkin, 
1981) 
Item parameters were estimated in the logistic metric using the marginal 
maximum likelihood (MML) method. The MML method assumes a specified 
distribution of the person parameter in the population (usually normal) and 
approximates that distribution by a quadrature procedure. For this reason, this method 
estimates item parameters first, and then estimates person parameters with the obtained 
item parameters. When estimating item parameters, it employs the expectation-
maximization (E-M) algorithm: the expectation step determines the expected number of 
examinees in the specified distribution at each of the pre-specified quadrature points. 
Then, the expected proportion of examinees at each point that would endorse the item is 
determined. In the maximization step, item parameters are estimated by the maximum 
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likelihood method. Estimation is repeated until the sum of the absolute changes in item 
parameters becomes very small. When all item parameters are estimated, the likelihood 
of the data matrix is assessed to see if it meets the defined criteria. The E-M cycle is 
iterated until the likelihood of the data matrix satisfies the convergence criteria.  
 
Item calibration 
 Items that met the IRT assumptions were calibrated using the one-parameter 
logistic (1PL) and two-parameter logistic (2PL) models respectively to determine which 
model is favored. A formal mathematical form of the model is  
Pi(θj|bi) = 1/{1+exp[-Dai(θj-bi)]} 
where ai represents the discrimination parameter for item i, bi is the difficulty parameter 
for item i, and D is a constant value of 1.0 (pure logistic) or 1.7 (logistic approximation 
to normal ogive). The 1PL model posits that all discrimination parameters are fixed and 
only difficulty parameters are allowed to vary. However, the 2PL model allows the 
discrimination parameters to vary across items as the difficulty parameters. Therefore, 
the discrimination parameter (ai) in the 1PL model is constant in the above equation.  
A discrimination parameter (ai) indicates the rate of a change in probability of 
endorsing the item i with a 1 unit change in θ at its steepest point in IRFs. 
Discrimination represents the strength of the relationship between an item and the latent 
construct similar to the item-total correlation in classical test theory, which is usually 
expressed as point-biserial correlation: 
ai = ρi / [(1-ρi)2]1/2 
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The difficulty parameter (bi) reflects the coping level at which the probability of 
endorsing the item i, that is, a probability that responding to a “yes” option is equal to 
0.5: 
bi = Φ-1 (pi / ρi) 
where Φ-1 is the normal inverse function, pi is the proportion of people who endorse the 
item i, and ρi is the point-biserial correlation of the item response with total score.  
 For example, Figure 3-1 below represents the hypothetical ICCs for two items. 
The ICCs show the relationship between the trait level and the probability of endorsing 
the items. Two items are monotonic, i.e., the probability of endorsing the item 
consistently increases as the trait level (θ) increases. Item 1 is a better discriminator of 
the trait than item 2 because the proportion of people endorsing the item changes 
relatively rapidly on item 1 as the trait level (θ) increases. The slope for item 2 is 
relatively flatter, indicating that it does not discriminate as well as item 1. For example, 
as a trait level (θ) increases from 0 to +2, the proportion people endorsing item 1 
increases from 5% to 70%, while the proportion of endorsing item 2 increases only 
from 70% to 90%. The ICCs also indicate that item 1 is more difficult than item 2 
because a trait level (θ) required to have 50% of probability of endorsing the item is 
further along the trait continuum for item 1 than item 2. That is, a trait level (θ) of -1 is 
required to have the probability of endorsing item 2, but a trait level (θ) is 1.5 to have 
the same probability of endorsing item 2.  




Item information function  
Item information can be obtained from the item information function (IIF) 
defined as the ratio of the squared slope of the item response function (IRF) to the item 
variance at each θ value: 
IIFi | θ = {pi’(θ)}2/ pi(θ)qi(θ) 
where pi’(θ) is the first derivative of the item response function (IRF) with respect to θ 
and qi(θ) is 1-pi(θ). This can be computed as follows for the 1PL and 2PL model, 
respectively (De Ayala, 2008): 
1PL: IIFi | θ =pi(θ)qi(θ) 
2PL: IIFi | θ =D2ai2pi(θ)qi(θ) 
Figure 3-1. Hypothetical item characteristic curves for two items 
 
θ 
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The equations indicate that the amount of information is conditional on θ in the 
1PL model and is proportional to ai2 in the 2PL model. Therefore, the height of IIF is 
associated with the discrimination of the item. That is, the better an item discriminates, 
the higher the IIF. In addition, the location of the IIF is associated with the item 
difficulty. After taking a derivative of these above equations, we can find a θ value that 
makes this derivative zero. The maximum information is obtained at this θ value. For 
the 1PL and 2PL model, this θ value is equal to bi, indicating that IIF reaches its peak at 
bi.   
By summing up item information for all items, test information is obtained. 
Alternatively, test information can be obtained from the test response function (TRF). In 
other words, the ratio of the squared slope of the TRF to its variance is defined as the 
test information function (TIF). TRF can be obtained either by summing the individual 
IRFs or by taking an average of all the IRFs. It indicates the “expected number correct” 
as a function of θ if IRFs are summed to compute TRF, or the “expected proportion 
correct” as a function of θ if IRFs are averaged to obtain TRF. Similar to item 
information, test information shows how well a test measures at each θ value; however, 
test information shows it at the test level, while item information is evaluated at each 
item level. TIFs display a θ value where a test has its maximum or substantial 
information along the whole θ continuum. The test can measure, most precisely, 
persons whose trait levels are around this θ value because the conditional test standard 
error of measurement (SEM) will be the lowest at this θ value. (The test SEM is the 
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reciprocal of the square root of the TIF.) Conversely, low TIF shows where a test has its 
largest SEM value and measures least precisely along the θ continuum.  
 
Comparisons of the 1PL model to the 2PL model 
To determine which model is preferred, the 1PL and 2PL model were compared 
by taking goodness-of-fit statistics, reliability of the estimated person scores, and 
standard error of measurement (SEM) into account. Goodness-of-fit to each model was 
assessed based on the deviance statistic (-2 log likelihood) and comparative fit measures 
such as Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC). 
The deviance statistics were used to examine if one model fit significantly better than 
the other model on the condition that one of the models was nested in the other. The 
model with the lower values of AIC and BIC indicated a better fit is preferred. In 
addition, a model with a higher reliability estimate is favored between the 1PL and 2PL 
model. Finally, the standard error of measurement and test information were 
investigated. A model with more information and less SEM over a range of the theta 
continuum is considered more desirable.  
To assess an each item’s fit to the model, an IRF diagnostic statistic was 
examined using the S-X2 statistic suggested by Orlando and Thissen (Orlando & 
Thissen, 2000; Orlando & Thissen, 2003). The IRF of the individual item is considered 
to fit sufficiently if the observed proportion of responding 0 (“no”) and 1 (“yes”) match 
the model-expected proportions. However, great deviations of the observed proportions 
from the expectations indicate an item’s poor fit. The statistically non-significant 
difference of the S-X2 statistic suggests an adequate item fit. In addition, overall model-
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data fit was evaluated using the M2 goodness-of-fit statistic and its associated RMSEA 
value. The M2 statistic, proposed by Maydeu-Olivares and Joe, is based on the one- and 
two-way marginal tables of the respondents classified by their response patterns 
(Maydeu-Olivares & Joe, 2006; Maydeu-Olivares & Joe, 2005). Adequate fit of the 
model to the data was indicated by non-significance of the M2 statistic or the RMSEA 
value below 0.1.  
 
Estimating the person parameters 
The person parameter, i.e., each person’s coping level (θ), was estimated using 
an expected a posteriori (EAP) method. Since this method adopts the Bayesian 
procedures, it modifies a likelihood function by a prior distribution to create a posterior 
distribution:  
f(θ|) = L(|θj) f(θj) 
where f(θ|) is the posterior function, L(|θj) is the likelihood function of the 
observations, and f(θj) is the prior distribution. 
EAP determines the θ estimates by computing the mean of the posterior 
distribution, given the observed response pattern. More specifically, the θ estimate is 
determined as the mean over quadrature points multiplied by the likelihood and the 
quadrature weight, i.e., the density of the prior distribution (Chen & Hou, 1997).  
EAP has some advantages over other estimating methods. First, EAP can be used to 
estimate for persons who get perfect scores or zero scores, which cannot be computed 
using the maximum likelihood estimation (MLE) method. In addition, EAP produces 
the lowest standard errors compared to MLE and maximum a posteriori (MAP), in 
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particular, in short-length tests (Wang & Vispoel, 1998). Because EAP does not involve 
an iterative process (e.g., Newton-Raphson) and employs the summation process, it is 
free from such concerns that an iteration is a time-consuming process and Newton-
Raphson may not converge. However, the EAP estimates were not as accurate as MAP 
estimates when numerous items with high discriminations at all θ levels were missing 
(Wang & Vispoel, 1998). Since the EAP estimates are regressed toward the mean of the 
prior distribution, these estimates may not be accurate if the prior distribution is not 
appropriate. The size and direction of such bias depends on the location of the mean of 
the prior distribution. In this study, a normal distribution was assumed as a prior 
distribution. 
In addition, a person’s total score was estimated by summing individual scores 
from each item in an IRT-metric to transform the summed scores to a T-score metric 
where mean is equal to 50 and standard deviation is 10.  
   
Differential item functioning (DIF) 
 Differential item functioning (DIF) is said to occur when individuals in one 
group respond differently to a certain item compared to individuals in the other group 
who possess the same level of the latent trait being measured. Therefore, difference in 
responses between these two groups is due to a group characteristic other than the latent 
trait. In IRT, DIF is considered to occur when the item response function differs for 
different groups. In other words, because the item response function is determined by 
the item parameters, items are evaluated for their DIF by comparing estimates of the 
item parameters between groups (Lord, 1977; Lord, 1980). In this study, DIF was 
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examined for all items between patients who perceived their ADP as moderate, small, 
or very small and those who perceived their ADP as big or very big. DIF was also 
evaluated between groups varying in demographics and health literacy levels: age 
(below the mean age (< 57) vs. equal to or above the mean age (≥ 57)), gender (male vs. 
female), education (some college or lower vs. college grad or higher), and health 
literacy level (low: not at all, a little bit, somewhat vs. high: quite a bit, extremely). To 
evaluate DIF, the Thissen, Steinberg, and Wainer (TSW) likelihood ratio test statistic 
implemented in IRTPRO was employed (De Ayala, 2008). Based on the TSW statistic 
which tests the null hypothesis of being no group differences in the item parameter 
estimates, the IRTPRO tests three null hypotheses: the estimated discrimination 
parameter is the same between the focal and reference group (H0: af = ar), the estimated 
intercept parameter (c = -a*b) conditional on the discrimination parameter is equal 
between two groups (H0: (c|a)f = (c|a)r), and both the estimated discrimination and 
intercept conditional on the discrimination parameter are the same across the groups 
(H0: af = ar, (c|a)f = (c|a)r). To test these hypotheses, the TSW approach involves a 
three-step procedure. For example, to test the first hypothesis for item 1 (H0: af = ar), it 
fits the 2PL model to both groups with the proviso that item discrimination parameter 
estimates for all items, except for item 1, are the same across the groups. For step 2, it 
fits the 2PL model, but all item discrimination parameter estimates including those of 
item 1 are constrained to be the same across both groups this time. The final step 
involves a computation of TSW-∆G2: 
TSW-∆G2 = (-2LL2) - (-2LL1) 
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where -2LL1 and -2LL2 are the likelihood ratios from step 1 and step 2. TSW-∆G2 is 
distributed as a X2 with two degrees of freedom since the discrimination and slope 
parameter estimates are both investigated simultaneously. A significant TSW-∆G2 
indicates the presence of DIF, whereas a non significant TSW-∆G2 indicates no DIF for 
the item under consideration. This three-step process is continued for all the items on 
the scale, and for testing the other two hypotheses.  
  
Development of a short-form of the scale 
For efficient use of the constructed medication problem coping scale (MPCS), a 
short-form was developed by considering the information provided by each item and its 
contextual importance in a clinical setting. The most informative items were selected, 
and items’ clinical importance was separately examined. The content of the final items 
in the short-form should cover the clinically meaningful coping behaviors 
comprehensively. 
 
The IRT diagnostic tests and parameter estimations were conducted with the software 
IRTPRO 2.1 (IRTPRO guide 2.1, Scientific Software International).  
 
3.4  Measures and predictions 
Problem Intensity. To measure how much of a problem a participant perceived, the 
participant was asked to respond to the question “To what extent, was the problem 
(identified in the previous question) for you?” This item was rated on a 5-point scale 
where 1 = very small problem; 2 = small problem; 3 = moderate problem; 4 = big 
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problem; and 5 = very big problem. According to the responses to this item, respondents 
were divided into five groups. A hypothesis was then formulated that coping scores 
would be different between these groups. That is, patients’ coping scores are expected 
to be relatively high when their ADP is perceived as comparatively big.  
 
Health Literacy. Health literacy was defined as “the degree to which individuals have 
the capacity to obtain, process, and understand basic health-related decisions” (Institute 
of Medicine, 2004). A previous study showed the usefulness of a single-item question 
for detecting inadequate health literacy by presenting its large area under the Receiver 
Operating Characteristic (ROC) curve of 0.74 (95% CI: 0.69 – 0.79) and 0.84 (95% CI: 
0.79 – 0.89) based on the 2 most widely used health literacy assessment scales, the 
Short Test of Functional Health Literacy in Adults (S-TOFHLA) and the Rapid 
Estimate of Adult Literacy in Medicine (REALM) (Chew et al., 2008). The single item 
asks patients how confident they are to fill out health forms by themselves on a 5-point 
scale (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = extremely). 
Limited health literacy has been shown to be associated with poor health outcomes such 
as poor health knowledge, poor medication adherence, and poor control of chronic 
illness (Schillinger et al., 2002; Williams, Baker, Parker, & Nurss, 1998). To better 
understand associations between health literacy and health outcomes, the previous 
literature has reported four components of health literacy (Al Sayah, Majumdar, 
Williams, Robertson, & Johnson, 2013; Berkman, Davis, & McCormack, 2010; 
Nutbeam, 2008): functional, interactive, critical, and numeracy skills. Functional 
literacy refers to one’s ability or skills to read written texts, understand and interpret 
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information in documents, and write and complete forms; Interactive literacy is one’s 
ability or skills to speak and listen to information and actively participate in 
communication; Critical literacy refers to one’s ability or skills to navigate the relevant 
systems (e.g., healthcare systems) to control situations; Numeracy literacy refers to 
one’s ability or skills to conduct mathematical tasks. Among these diverse types of 
skills, the functional skill is expected to be possibly associated with a patient’s coping 
behaviors of discussing an ADP with others. Also, this critical skill can be positively 
associated with a patient’s information seeking behaviors in the scale. That is, if a 
patient is able to search the healthcare systems to manage the situation, the patient is 
expected to seek information to handle an ADP. Therefore, persons with a high level of 
health literacy were expected to possess a high coping level. 
 
Coping Self-Efficacy (CSE). The CSE scale was designed to measure respondents’ 
perceived self-efficacy to deal with psychological challenges or threats (Chesney, 
Neilands, Chambers, Taylor, & Folkman, 2006). The stem question is “When things 
aren’t going well for you, or when you are having problems, how confident or certain 
are you that you can do the following?” and then the scale presents 13 items that tap 
three distinct dimensions: use problem-focused coping (6 items, alpha = 0.91), stop 
unpleasant emotions and thoughts (4 items, alpha = 0.91), and get support from friends 
and family (3 items, alpha = 0.80). Respondents are asked to rate their confidence with 
each statement on an 11-point scale, ranging from 0 = “cannot do at all” to 5 = 
“moderately certain can do” to 10 = “certain can do.” In this study, the three items 
which had the highest factor loadings on the problem-focused coping subscale were 
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employed (i.e., “sort out what can be changed, and what cannot be changed,” “break an 
upsetting problem down into smaller parts,” and “make a plan of action and follow it 
when confronted with a problem.”). According to Albert Bandura, self-efficacy was 
defined as “one’s own capabilities to organize and execute the courses of action 
required to manage prospective situations (Bandura, 1997).” Since self-efficacy is 
conceptually related to beliefs about capabilities of conducting specific behaviors in 
particular situations (Schunk & Carbonari, 1984), it can affect a person’s coping 
behaviors when the person faces a problem with the purpose of managing and 
controlling the problem. This has been supported by the previous studies that showed 
relationships between self-efficacy and behavior change such as smoking cessation, 
weight control, or use of contraception (Chambliss & Murray, 1979; Gilchrist & 
Schinke, 1983; Nicki, Remington, & MacDonald, 1984). Therefore, this study 
hypothesized that persons with a higher coping level would possess a higher coping 
self-efficacy than those with a lower coping level.  
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Chapter 4 : RESULTS  
This Chapter includes the main findings from the psychometric analyses and 
hypothesis testing of the study. More specifically, it presents an initial item pool, a 
description of the respondents and responses, confirmatory factor analysis results, IRT 
analysis results, a final item pool, and correlations between the coping level and other 
constructs. 
 
4.1  Patient characteristics, reported ADPs, and ADP-related medications 
 A total of 140 patients (55 males, 85 females) who had experienced medication-
related ADP(s) completed the questionnaire. Their ages ranged from 18 to 91 years old, 
with a mean age of 56.9 (SD = 15.4) and about 97% of them were White. Among 140 
patients, three subjects did not answer the question asking about their medication-
related ADP. Also, thirteen out of 140 patients did not respond to the question asking 
about the ADP-related medication. These non-respondents did not want to reveal their 
ADP or medication name for their privacy. Alternatively, some of them used multiple 
medications and did not know which medication was associated with their ADP. 
However, all 140 patients provided demographic information and answered 23 yes/no 
questions asking whether they used each coping strategy presented to them. These 140 
patients were compared with 63 patients who did not experience of ADP(s) but 
provided demographic information and number of medications being taken (Table 4-1). 
The number of medication(s) was significantly higher in patients with ADP(s) (mean = 
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4.71, SD = 2.99) compared to those without ADP(s) (mean = 2.98, SD = 2.35) (t (150) 
= 4.33, p = .000). This indicates that chances of experiencing ADP(s) are higher in 
patients using more medications compared to those who take less medication(s). 
However, there was no significant difference in demographic characteristics (e.g., age, 
gender, race, education level, and working status) and the percent of those with health 
insurance and healthcare background between these two groups.  
 
Table 4-1. Comparison of patients with an adverse drug problem (ADP) to patients without 
ADP* 
 Patients with ADP 
(n=140) 
Patients with no ADP 
(n=63) 
t or X2 Sig. 
Number of medication use 4.71 (SD: 2.99), 
Range: 1-15 
2.98 (SD: 2.35), 
Range: 1-11 
t = 4.331 0.000 
Age (yr) 56.86 (SD: 15.41), 
Range: 18-91 
60.37 (SD: 18.73), 
Range: 21-89  
t = 1.401 0.551 
Female, n (%) 85 (60.7) 32 (50.8) X2 = 1.751 0.186 
White, n (%) 136 (97.1) 62 (98.4) X2 = 0.292 0.589 
College grad or more, n (%) 66 (48.2) 31 (50.0) X2 = 0.057 0.811 
Currently working, n (%) 69 (50.4) 23 (36.5) X2 = 3.336 0.068 
Health insurance, n (%) 139 (99.3) 60 (95.2) X2 = 3.685 0.055 
Healthcare background, n (%) 29 (21.2) 10 (15.9) X2 = 0.771 0.380 
* Differences between these two groups were examined using an independent t-test for continuous variables and 
chi-square analyses for categorical variables. 
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Patients’ perceived ADPs are presented in Figure 4-1. A total of 30 different 
ADPs were reported by one hundred thirty seven patients. Overall the most frequently 
described ADP was a dry mouth (11.7%) followed by a fatigue/tiredness/lack of energy 
(10.2%). Eight different ADPs were reported by only a single patient. Those ADPs were 
anxiety, breast enlargement, cough/sore throat, hair loss, hallucination, increased 
appetite, altered taste, and twitching (facial). Respondents and ADPs were then 
categorized by the problem intensity they reported. Ten patients perceived their ADPs 
as very small; 24 as small; 44 as moderate; 32 as big; and 27 as very big. The ADP 
types and their reported frequency differed in each category. Although dizziness and 
dry mouth were the most frequently reported ADPs in patients who perceived their 
problem as very small or small, breathing problems and muscle/joint pain were the most 
common ADPs in those who considered their problem very big. A dry mouth problem 
was not stated in this group of patients while convulsion and rapid heart rate or heart 
attack were uniquely reported by these patients. The problems such as a 
fatigue/tiredness/lack of energy and dry mouth were the most frequently addressed 
among those who perceived their ADP(s) as big. Notably, a fatigue/tiredness/lack of 
energy problem was commonly reported in all categorized patient groups. However, the 
problem intensity varied from very small to very big, which suggests the importance of 
patients’ perspectives in assessing the problem intensity and coping with this problem 
rather than others’ perspectives.  
 
 




Figure 4-1. Number of patients who perceived adverse drug problems (ADPs) 
 
*Others: Eight different ADPs (anxiety, breast enlargement, cough/sore throat, hair loss, hallucination, 
increased appetite, taste problem, and twitching (facial problem)), each with a single response 





Figure 4-2. Number of patients who perceived their adverse drug problem (ADP) as 
very small 
Figure 4-3. Number of patients who perceived their adverse drug problem (ADP) as 
small
 




Figure 4-4. Number of patients who perceived their adverse drug problem (ADP) as 
moderate
 
Figure 4-5. Number of patients who perceived their adverse drug problem (ADP) as big 
 










Figure 4-4. Number of patients who perceived their adverse drug problem (ADP) as very 
big 
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Table 4-2 shows the patients’ various reasons for taking medication which were 
associated with their perceived ADPs. One hundred twenty seven patients answered a 
question asking about the name of their ADP-related medication while thirteen patients 
did not respond to this question for the reasons noted earlier. The medications for the 
treatment of heart disease and infection were most frequently reported as being 
associated with an ADP by this study sample. Antidepressants were also commonly 
identified as the ADP-associated medication. There were only two patients who 
attributed their ADPs to anticancer medications in this study sample. When patients 
reported their ADP and the medication that they designated as being associated with it, 
their reported ADPs were consistent with known side effects of the medication in 
almost all cases.  
However, we did not examine if a patient’s reason for taking medication was 










Table 4-2. Patients' reasons to take medications 
Reason for medication use Number of patients % 
Heart disease 28 22.0 
Infection (e.g., AIDS, Lyme disease) 28 22.0 
Depression or anxiety 20 15.7 
Pain  10 7.9 
Diabetes 9 7.1 
Epilepsy or seizure 6 4.7 
Hormone-related treatment 5 3.9 
Schizophrenia 4 3.1 
Benign Prostatic Hyperplasia (BPH) 3 2.4 
Inflammation (e.g., Crohn’s disease, Rheumatic arthritis) 3 2.4 
Cancer 2 1.6 
Gastrointestinal disease 2 1.6 
Osteoporosis 2 1.6 
Overactive bladder 2 1.6 
Asthma 1 0.8 
Restless Legs Syndrome (RLS) 1 0.8 
Immunosuppressant 1 0.8 
Total 127 100 
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4.2  Item selection 
A total of 23 items were initially included in the item pool. These items and the 
number of “yes” responses to each item are presented in Table 4-3. Patients’ most 
frequently reported coping behavior was to discuss the problem with their physician or 
nurse. One hundred twelve respondents (80.0%) showed that they employed this 
discussion coping to deal with their ADP. Most of them (62.9%) also discussed it with 
their family or friends. In addition, more than 50% of patients employed the coping 
behaviors such as trying to learn if the problem was related to their medication use, or 
visiting their physician or nurse to fix the problem. However, only five patients reduced 
the dose of the medication and one patient used their medication less frequently without 
discussing it with their providers in response to their ADP. There were twenty-three 
patients who had visited emergency rooms (ERs) or been hospitalized because of their 
ADP. 




Table 4-3. Frequencies of employing each coping strategy (n=140)* 
Items Number of “yes” responses, n (%) 
To handle the medication-related problem identified, did you…  
Item 13: Discuss the problem with your physician or nurse? 112 (80.0%) 
Item 11: Discuss the problem with your family or friends? 88 (62.9%) 
Item 8: Try to learn more about if the problem is related to your medication? 78 (55.7%) 
Item 2: Continue to use the medication as prescribed in spite of the problem? 73 (52.1%) 
Item 21: Visit your physician or nurse to resolve the problem? 72 (51.4%) 
Item 1: Entirely stop using the medication? 62 (44.3%) 
Item 14: Ask your physician or nurse to prescribe a different medication? 60 (42.9%) 
Item 7: Search for written information about the problem (on the internet, in a book, etc)? 57 (40.7%) 
Item 15: Limit your activities or change your daily routines? 55 (39.3%) 
Item 12: Discuss the problem with your pharmacist? 54 (38.6%) 
Item 10: Seek out information that would help you resolve the problem? 49 (35.0%) 
Item 9: Try to see if other people like you experienced the same problem you had? 41 (29.3%) 
Item 17: Get another prescription medication to treat the problem? 32 (22.9%) 
Item 18: Use a non-prescription medication to treat the problem? 26 (18.6%) 
Item 16: Take sick time or work less than usual? 24 (17.1%) 
Item 20: Visit your pharmacist to resolve the problem? 22 (15.7%) 
Item 19: Use home remedy to treat the problem? 15 (10.7%) 
Item 22: Visit an emergency department or go to urgent care? 13 (9.3%) 
Item 23: Get admitted to the hospital? 10 (7.1%) 
Item 4: Reduce the dose of the medication? 5 (3.6%) 
Item 5: Use a non-prescription medication instead of using the medication? 5 (3.6%) 
Item 6: Use home remedy instead of using the medication? 2 (1.4%) 
Item 3: Use the medication less frequently? 1 (0.7%) 
* Items are ordered by the frequencies of being employed. 
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When conducting CFA to examine the unidimensionality assumption, only 
sixteen items were included from the initial 23-item pool after excluding three items 
and grouping similar items together (Figure 4-7). Two items were excluded because 
they were ADP-dependent and thus not applicable to all medication-related problems 
(items 5 and 6). There was no non-prescription medication or home remedy to replace 
the prescription medication for a certain disease (e.g., schizophrenia, cancer); thus, 
patients with such diseases were not able to answer item 5 (“used a non-prescription 
medication instead of using the medication.”) and item 6 (“used home remedy instead 
of using the medication.”), which was the reason why these items were eliminated in 
CFA. Moreover, item 2 (“continued to use the medication as prescribed in spite of the 
problem.”) was excluded in CFA because patients’ responses to this item were coded 
exactly the same as the coding for item 1 (“entirely stop using the medication.”) when 
reverse-coding item 2 to conduct CFA. Also, the content of item 2 (i.e., continuation of 
using the medication as prescribed despite the problem) indicates that a patient did not 
cope with an ADP while this study focuses on how patients handled the problem on the 
assumption that they did cope. In addition, several items were grouped together to 
create a new item to reduce a patient’s response burden by shortening the questionnaire 
while keeping the construct content covered by such items. For example, some patients 
were not able to respond to item 18 (“used a non-prescription medication to treat the 
problem.”) and item 19 (“used home remedy to treat the problem.”) for the same reason 
as items 5 and 6. However, instead of being removed in this case, these two items were 
combined with item 17 (“got another prescription medication to treat the problem.”) to 
create a new item (“got another medication or home remedy to treat the problem.”) to 
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keep their construct content. This new item replaced three items (item 17, 18, and 19) in 
CFA, coded as “1” (“yes” response) if any of these three items had a “yes” response, 
otherwise as “0” (“no” response). Moreover, some items were combined not to 
distinguish between healthcare providers which was separately termed as “pharmacist” 
or “physician or nurse” in the items. In assessing a patient’s coping response to an ADP, 
it is more important to know whether the patient discussed with or visited a healthcare 
provider than whom the patient discussed with or visited. Therefore, a term 
“pharmacist” in item 12 and 20 and “physician or nurse” in item 13 and 21 were 
grouped together and replaced by a “healthcare provider” in the new items. Thus, two 
new items (“discussed the problem with my healthcare provider,” and “visited my 
healthcare provider to resolve the problem.”) were included in CFA replacing item 12 
(“discussed the problem with my pharmacist.”), item 13 (“discussed the problem with 
my physician or nurse.”), item 20 (“visited my pharmacist to resolve the problem.”), 
and item 21 (“visited my physician or nurse to resolve the problem.”).  
After removing three items (item 5, 6, and 2) and combining similar items 
together, nonlinear CFA was performed with a total of 16 remaining items. The initial 
CFA results with these items showed that some items were negatively or weakly 
correlated with other items, resulting in an inadequate model fit. Therefore, the most 
distinct item based on its weak or negative correlations with other items was first 
removed in the following CFA. Since the correlations between items and the fit indexes 
were still unsatisfactory, this procedure of eliminating such items was continued until 
all remaining items showed acceptable correlations with other items. When the five 
items (item 3, 4, 7, 8, and 9) were removed while leaving 11 items in CFA, the 
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correlations and fit indexes were reasonable. Although some correlations were very 
weak or very strong between these items, 95.5% of the correlations were in the range of 
0.2 to 0.8 (Table 4-4). Goodness-of-fit indexes indicated that with the revised set of 11 

























Figure 4-7. Item selection processes 
 Initial 23-item pool 
Excluded (n=3): 
- ADP-dependent items (n=2) 
- Items with a redundant coding (n=1) 
CFA with 16 items 
Excluded (n=5): 
- Items violating the unidimension assumption 
 
IRT analysis with 11 items 
Examination of item fit: 
- No exclusion of item 
Final 11-item pool 
Replaced (n=7) by new items (n=3): 
- Items with similar meaning combined  




ADP: adverse drug problem, IRT: item response theory 
 
 







Table 4-4. Interitem polychoric (tetrachoric) correlation matrix 
 Item 1 Item 10 Item 11 Item 12-13* Item 14 Item 15 Item 16 Item 17-19* Item  20-21* Item 22 Item 23 
Item 1            
Item 10 0.160           
Item 11 0.513 0.370          
Item 12-13* 0.625 0.414 0.287         
Item 14 0.614 0.380 0.485 0.716        
Item 15 0.261 0.328 0.507 0.210 0.470       
Item 16 0.504 0.457 0.575 0.526 0.714 0.872      
Item 17-19* 0.444 0.191 0.257 0.459 0.401 0.288 0.360     
Item 20-21* 0.433 0.550 0.364 0.802 0.738 0.560 0.676 0.491    
Item 22 0.692 0.268 0.623 0.368 0.583 0.515 0.740 0.763 0.700   
Item 23 0.715 0.202 0.562 0.300 0.726 0.669 0.708 0.616 0.643 0.865  
* Combined items due to their content similarities 
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4.3  Psychometric analyses 
After confirming unidimensionality of the 11 items with reasonable fit indexes in 
CFA, the local independence assumption was examined for these items. As shown in 
Table 4-5, there was no considerable large value of standardized LD X2 statistics (e.g., > 
10) for any item. The largest value of standardized X2 in the Table was 5.1, which 
indicates no items violated the local independence assumption.  
Since these 11 items met the unidimensionality and local independence 
assumptions, they were renumbered and calibrated using the 1PL and the 2PL model. The 
estimated item parameters from these models are listed in Table 4-6 and Table 4-7, 
respectively. Results using the 1PL model showed that the discrimination parameter was 
fixed as 1.71 and the difficulty parameter varied from -1.42 to 2.13. The discrimination 
parameter obtained using the 2PL model ranged from 0.87 to 5.08 with a mean value of 
2.36, indicating moderate to very high discriminating abilities of these items. 
Discrimination parameters ranging from 0.01 to 0.24 have been considered as very low 
discrimination, from 0.25 to 0.64 as low, from 0.65 to 1.34 as moderate, from 1.35 to 
1.69 as high, larger or equal to 1.70 as very high (Baker, 2001). The range of the 
difficulty parameter estimates using the 2PL model (from -1.20 to 1.55) spanned a 
narrower range compared to the range of the estimates obtained using the 1PL model. 
Although there was no considerable difference in the estimated absolute values of the 
difficulty parameters between the 1PL model and the 2PL model, two items (item 5 and 
8) were relatively located differently on these two models when ordered by their values 
of difficulty parameters. On the 1PL model, the difficulty parameter of item 5 was 
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estimated relatively highly compared to the estimated difficulty parameters of the other 
items. 





Table 4-5. Marginal fit (X2) and standardized LD X2 statistics 
 Item 1 Item 10 Item 11 Item 12-13* Item 14 Item 15 Item 16 Item 17-19* Item  20-21* Item 22 Item 23 
Item 1            
Item 10 0.2           
Item 11 0.3 -0.2          
Item 12-13* -0.5 -0.7 0.5         
Item 14 -0.4 -0.7 -0.7 -0.6        
Item 15 0.4 -0.6 0.5 3.0 -0.6       
Item 16 -0.6 -0.6 -0.3 - -0.7 5.1      
Item 17-19* -0.4 -0.5 -0.6 -0.7 -0.5 -0.6 -0.2     
Item 20-21* 0.5 0.4 0.1 -0.2 -0.7 -0.7 -0.6 -0.7    
Item 22 -0.4 -0.1 0.2 - - -0.6 -0.6 1.7 -   
Item 23 0.1 0.6 - - - -0.5 -0.1 -0.5 - -0.7  
* Combined items due to their content similarities 




Table 4-6. Item parameter estimates and fit statistics using the one-parameter logistic (1PL) model* 
Items Item parameters  S-X2 fit index 
a SE b  SE  X2 df p 
To handle the medication-related problem identified, did you…         
Item 4: Discuss the problem with your healthcare provider? 1.712 0.204 -1.422 0.207  2.499 3 0.476 
Item 3: Discuss the problem with your family or friends? 1.712 0.204 -0.473 0.149  7.644 6 0.267 
Item 9: Visit your healthcare provider to resolve the problem? 1.712 0.204 -0.142 0.144  5.143 5 0.400 
Item 8: Get another medication or home remedy to treat the problem? 1.712 0.204 0.159 0.147  9.526 6 0.146 
Item 1: Entirely stop using the medication? 1.712 0.204 0.184 0.147  5.224 6 0.517 
Item 5: Ask your physician or nurse to prescribe a different medication? 1.712 0.204 0.235 0.149  6.356 5 0.275 
Item 6: Limit your activities or change your daily routines? 1.712 0.204 0.364 0.154  5.630 6 0.467 
Item 2: Seek out information that would help you resolve the problem? 1.712 0.204 0.524 0.163  23.084 6 0.0008 
Item 7: Take sick time or work less than usual? 1.712 0.204 1.339 0.219  10.804 6 0.094 
Item 10: Visit an emergency department or go to urgent care? 1.712 0.204 1.907 0.281  8.131 4 0.087 
Item 11: Get admitted to the hospital? 1.712 0.204 2.129 0.309  4.701 3 0.196 
* Items are ordered by their values of difficulty parameters. a: discrimination parameter, b: difficulty parameter. 
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Table 4-7. Item parameter estimates and fit statistics using the two-parameter logistic (2PL) model* 
Items Item parameters  S-X2 fit index 
a SE b  SE  X2 df p 
To handle the medication-related problem identified, did you…         
Item 4: Discuss the problem with your healthcare provider? 2.746 0.906 -1.197 0.214  0.776 2 0.679 
Item 3: Discuss the problem with your family or friends? 1.133 0.297 -0.586 0.234  5.176 6 0.523 
Item 9: Visit your healthcare provider to resolve the problem? 2.980 0.819 -0.111 0.142  1.869 4 0.760 
Item 5: Ask your physician or nurse to prescribe a different medication? 2.594 0.633 0.212 0.156  4.128 5 0.532 
Item 1: Entirely stop using the medication? 1.485 0.348 0.214 0.182  4.141 6 0.658 
Item 8: Get another medication or home remedy to treat the problem? 1.113 0.284 0.223 0.199  2.738 7 0.908 
Item 6: Limit your activities or change your daily routines? 1.324 0.335 0.436 0.192  3.670 6 0.722 
Item 2: Seek out information that would help you resolve the problem? 0.870 0.252 0.823 0.300  9.054 7 0.248 
Item 7: Take sick time or work less than usual? 2.880 1.262 1.111 0.157  7.224 4 0.124 
Item 10: Visit an emergency department or go to urgent care? 3.800 1.696 1.460 0.193  2.831 2 0.244 
Item 11: Get admitted to the hospital? 5.079 1.083 1.549 0.143  1.101 2 0.577 
* Items are ordered by their values of difficulty parameters. a: discrimination parameter, b: difficulty parameter. 
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 When items were ordered by their values of difficulty parameters, the location of 
item 5 was ranked as the sixth from the lowest on the 1PL model. However, this item was 
located as the fourth from the lowest on the 2PL model due to its relatively low estimated 
value of difficulty parameter. This item positioned differently on two models because the 
discrimination was fixed as 1.71 for the 1PL model, whereas it was estimated as 2.59 for 
the 2PL model. In addition, item 8 had a lower difficulty value than item 1 for the 1PL 
model, which was not the case for the 2PL model. When calibrating using the 2PL model, 
the value of the difficulty parameter of item 8 (0.22) was slightly higher than that of item 
1 (0.21). To handle these inconsistencies between two models and decide a better model, 
the item fit to each model was examined. When calibrating using the 1PL model, the S-X2 
statistic showed statistical non-significance for all items but for item 2 (S-X2(6) = 23.1, p 
< 0.001). However, all items showed an adequate item fit indicated by statistical non-
significance of the S-X2 statistic for the 2PL model. Therefore, the estimations of the item 
parameters obtained using the 2PL model were considered more reasonable. 
 In addition to the comparison at this item-level, the 1PL and the 2PL models were 
compared at the model-level to determine which model is preferred. First, model-data fit 
was assessed using the deviance statistic (-2 log likelihood) and comparative fit measures 
such as AIC and BIC (Table 4-8). The deviance statistic (-2 log likelihood) for the 1PL 
and the 2PL model were reported as 1478.76 (df = 54) and 1437.14 (df = 44), 
respectively. The chi-squared difference test was highly significant (X2(41.61, 10), p < 
0.0001) indicating that the 2PL model provided a better fit to the item responses 
compared to the 1PL model. This result was supported by the information–theoretic fit 
index (AIC) and the RMSEA value, all of which favored the 2PL model. However, the 
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values of the BIC were almost the same in these two models, which made comparisons 
difficult based solely on this fit measure. Second, reliability of the estimated scores was 
examined for each model. Consistent with the previous results, the 2PL model was 
preferred with a higher value of score reliability estimate (0.82) compared to that of the 
1PL model (0.79).  
 
 Finally, the standard error of measurement and test information was investigated 
for each model (Figures 4-8, 4-9 and Tables 4-9, 4-10). The 2PL model had much more 
information and much lower SEM over most of the coping behavior range. The 1PL 
model had slightly more information and lower SEM only when the coping level ranged 
from -2.8 to -2.0 and from 2.2 to 2.8. The relative efficiency index (REI) of the 2PL 
model over 1PL was shown in Figure 4-10. The coping level around 0.4, where the 1PL 
model can measure the coping level most precisely along the theta continuum, was even 
more precisely measured by the 2PL model. That is, the 2PL model had more 
information, less measurement error, and therefore better precision even where the 
coping level was most precisely measured by the 1PL model. Those whose coping level 
was around 1.6 were most precisely measured by the 2PL model. All of these findings 
suggested that the 2PL model was preferred than the 1PL model.  
Table 4-8. Comparisons between the one-parameter logistic (1PL) and two-parameter logistic 
(2PL) model 
  1PL 2PL 
Fit -2LL 1478.755 (df = 54) 1437.144 (df=44) 
 AIC 1502.755 1481.144 
 BIC 1538.055 1545.860 
 RMSEA 0.08 0.06 
Reliability Marginal reliability for response pattern score 0.79 0.82 
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Figure 4-11displays the item response function and item information function for each 





Figure 4-8. Standard error of measurement (SEM) for the one-parameter logistic 
(1PL) and two-parameter logistic (2PL) model 
 





Figure 4-9. Test information for the one-parameter logistic (1PL) and two-parameter 
logistic (2PL) model  
Figure 4-10. Relative Efficiency Index (REI) 
 




Table 4-9. Item information and test information measured using the one-parameter logistic (1PL) model 
Item Theta 
 -2.8 -2.4 -2.0 -1.6 -1.2 -0.8 -0.4 0 0.4 0.8 1.2 1.6 2.0 2.4 2.8 
Item 1 0.02 0.03 0.07 0.13 0.23 0.39 0.58 0.71 0.71 0.56 0.37 0.22 0.12 0.06 0.03 
Item 2 0.01 0.02 0.04 0.07 0.14 0.25 0.41 0.60 0.72 0.69 0.53 0.35 0.20 0.11 0.06 
Item 3 0.05 0.10 0.19 0.32 0.51 0.68 0.73 0.62 0.44 0.27 0.15 0.08 0.04 0.02 0.01 
Item 4 0.23 0.39 0.58 0.72 0.71 0.56 0.37 0.22 0.12 0.06 0.03 0.02 0.01 0.00 0.00 
Item 5 0.02 0.03 0.06 0.12 0.21 0.36 0.55 0.70 0.72 0.58 0.40 0.24 0.13 0.07 0.04 
Item 6 0.01 0.03 0.05 0.09 0.18 0.31 0.49 0.67 0.73 0.64 0.46 0.28 0.16 0.08 0.04 
Item 7 0.00 0.00 0.01 0.02 0.04 0.07 0.14 0.24 0.41 0.60 0.72 0.70 0.54 0.35 0.21 
Item 8 0.02 0.04 0.07 0.13 0.24 0.40 0.59 0.72 0.70 0.55 0.36 0.21 0.12 0.06 0.03 
Item 9 0.03 0.06 0.11 0.21 0.35 0.54 0.70 0.72 0.60 0.41 0.24 0.13 0.07 0.04 0.02 
Item 10 0.00 0.00 0.00 0.01 0.01 0.03 0.05 0.10 0.19 0.33 0.52 0.68 0.73 0.62 0.43 
Item 11 0.00 0.00 0.00 0.00 0.01 0.02 0.04 0.07 0.14 0.25 0.41 0.60 0.72 0.69 0.54 
Test information 1.39 1.70 2.18 2.82 3.62 4.61 5.65 6.39 6.47 5.94 5.20 4.51 3.84 3.11 2.40 
Expected SE 0.85 0.77 0.68 0.60 0.53 0.47 0.42 0.40 0.39 0.41 0.44 0.47 0.51 0.57 0.65 
 




Table 4-10. Item information and test information measured the two-parameter logistic (2PL) model 
Item Theta 
 -2.8 -2.4 -2.0 -1.6 -1.2 -0.8 -0.4 0 0.4 0.8 1.2 1.6 2.0 2.4 2.8 
Item 1 0.02 0.04 0.08 0.13 0.21 0.33 0.45 0.54 0.54 0.46 0.34 0.22 0.14 0.08 0.05 
Item 2 0.03 0.04 0.06 0.07 0.09 0.12 0.14 0.17 0.18 0.19 0.18 0.17 0.15 0.12 0.10 
Item 3 0.09 0.13 0.18 0.23 0.29 0.32 0.32 0.29 0.24 0.18 0.13 0.09 0.06 0.04 0.03 
Item 5 0.09 0.26 0.67 1.41 1.88 1.42 0.68 0.26 0.09 0.03 0.01 0.00 0.00 0.00 0.00 
Item 6 0.00 0.01 0.02 0.06 0.16 0.42 0.95 1.56 1.59 0.99 0.45 0.17 0.06 0.02 0.01 
Item 7 0.02 0.04 0.06 0.10 0.16 0.24 0.33 0.40 0.44 0.41 0.34 0.25 0.17 0.11 0.07 
Item 8 0.00 0.00 0.00 0.00 0.01 0.03 0.10 0.31 0.84 1.71 2.04 1.31 0.55 0.19 0.06 
Item 9 0.04 0.06 0.09 0.13 0.18 0.23 0.28 0.30 0.31 0.28 0.23 0.18 0.13 0.09 0.06 
Item 10 0.00 0.01 0.03 0.10 0.32 0.89 1.85 2.16 1.31 0.52 0.17 0.05 0.02 0.00 0.00 
Item 11 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.06 0.25 1.01 2.86 3.36 1.45 0.38 0.09 
Item 12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.55 3.20 6.34 2.15 0.33 0.04 
Test information 1.30 1.59 2.19 3.24 4.31 5.01 6.12 7.06 6.85 7.33 10.96 13.16 5.89 2.39 1.51 
Expected SE 0.88 0.79 0.68 0.56 0.48 0.45 0.40 0.38 0.38 0.37 0.30 0.28 0.41 0.65 0.81 
 




Figure 4-11. Item response function and item information function measured using the two-parameter logistic (2PL) model 
 
 Blue line represents item response function (IRF); Black line represents 1-IRF; Black dotted line indicates item information function (IIF). 
 








Figure 4-12. Test response function (TRF) measured using the two-parameter 
logistic (2PL) model  
 
 
Test response function (TRF) is the sum of the individual item response function (IRF). TRF 
indicates the expected number of endorsing items as a function of theta.  
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4.4  Differential item functioning (DIF) 
Table 4-11and 4-12 provide DIF statistics and parameter estimates for different 
problem intensity groups. Three items (items 4, 7, and 10) showed significant X2 results, 
which may indicate the presence of DIF. However, the significant results in these items 
stemmed from unreliably large estimates of discrimination parameter in any of two 
groups rather than their differential functioning between two groups. The unreliable 
estimates of parameters (e.g., 26.40, 30.07, and 45.52) were obtained because of response 
categories with very few observations (i.e., strongly skewed distributions) for these items. 
Items with sparse cell distributions have generally been known to be problematic in 
obtaining reliable estimates of parameters. Therefore, DIF for these three items needs to 
be reexamined in large samples after obtaining adequate estimates of parameters.  
Three Items with significant X2 results in investigating demographic DIFs (gender 
DIF, education DIF, age DIF) and health literacy level DIF had the same problem (Table 
4-13, 4-14. 4-15, 4-16, 4-17, 4-18, 4-19, and 4-20). That is, some parameters of these 
items were estimated unreliably high in a subgroup due to very few observations in a 
response category. Such items include items 4, 10, and 11 for demographic DIFs and 
items 1, 6, and 7 for health literacy DIF. DIF for these items should also be reinvestigated 
when each response category in the items has enough observations to obtain reliable 








Table 4-11. Problem intensity differential item functioning (DIF) statistics 
Item Moderate, small, or very small (n=81) Big or very big (n=59) Total X2 df p Xa2 df p Xc|a2 df P 








Item 1 61 (75.3) 20 (24.7) 17 (28.8) 42 (71.2) 1.4 2 0.492 0.6 1 0.424 0.8 1 0.378 
Item 2 62 (76.5) 19 (23.5) 29 (49.2) 30 (50.8) 0.9 2 0.644 0.8 1 0.360 0.0 1 0.840 
Item 3 45 (55.6) 36 (44.4) 7 (11.9) 52 (88.1) 6.0 2 0.051 0.6 1 0.450 5.4 1 0.020 
Item 4 18 (22.2) 63 (77.8) 4 (6.8) 55 (93.2) 101.5 2 0.0001 81.4 1 0.0001 20.2 1 0.0001 
Item 5 60 (74.1) 21 (25.9) 20 (33.9) 39 (66.1) 1.2 2 0.542 0.4 1 0.512 0.8 1 0.374 
Item 6 65 (80.2) 16 (19.8) 20 (33.9) 39 (66.1) 3.9 2 0.145 0.4 1 0.539 3.5 1 0.062 
Item 7 77 (95.1) 4 (4.9) 39 (66.1) 20 (33.9) 84.6 2 0.0001 12.6 1 0.0004 72.0 1 0.0001 
Item 8 58 (71.6) 23 (28.4) 19 (32.2) 40 (67.8) 0.8 2 0.656 0.3 1 0.580 0.5 1 0.465 
Item 9 53 (65.4) 28 (34.6) 12 (20.3) 47 (79.7) 3.7 2 0.155 1.4 1 0.244 2.4 1 0.123 
Item 10 79 (97.5) 2 (2.5) 48 (81.4) 11 (18.6) 113.7 2 0.0001 100.3 1 0.0001 13.4 1 0.0003 
Item 11 80 (98.8) 1 (1.2) 50 (84.7) 9 (15.3) 0.2 2 0.883 0.2 1 0.639 0.0 1 0.866 
 




Table 4-12. Item parameter estimates for different problem intensity groups 
Items Moderate, small, or very small  Big or very big 
a SE c  SE  a SE c  SE 
To handle the medication-related problem identified, did you…          
Item 1: Entirely stop using the medication? 1.36 0.54 -1.39 0.46  0.79 0.46 -0.36 0.74 
Item 2: Seek out information that would help you resolve the problem? 0.44 0.36 -1.20 0.31  0.96 0.45 -1.60 0.82 
Item 3: Discuss the problem with your family or friends? 0.35 0.30 -0.21 0.23  0.85 0.60 0.73 0.87 
Item 4: Discuss the problem with your healthcare provider? 45.52 4.50 34.84 4.52  2.62 1.53 -0.24 1.47 
Item 5: Ask your physician or nurse to prescribe a different medication? 3.68 2.13 -2.38 1.35  2.19 0.79 -2.70 1.19 
Item 6: Limit your activities or change your daily routines? 0.48 0.35 -1.44 0.31  0.84 0.45 -0.69 0.79 
Item 7: Take sick time or work less than usual? 30.07 7.96 -43.96 4.34  1.58 1.05 -3.58 2.02 
Item 8: Get another medication or home remedy to treat the problem? 0.64 0.36 -0.97 0.32  0.95 0.42 -0.77 0.65 
Item 9: Visit your healthcare provider to resolve the problem? 2.20 0.88 -0.99 0.54  4.17 1.44 -3.91 1.45 
Item 10: Visit an emergency department or go to urgent care? 26.40 2.20 -45.30 5.07  2.94 0.81 -7.68 1.78 
Item 11: Get admitted to the hospital? 25.40 43.53 -48.55 327.24  4.96 0.91 -13.03 1.84 
a: discrimination parameter, c: - a*b (b: difficulty parameter). 




Table 4-13. Gender differential item functioning (DIF) statistics 









Item 1 31 (56.4) 24 (43.6) 47 (55.3) 38 (44.7) 2.3 2 0.324 2.3 1 0.135 0.0 1 0.911 
Item 2 35 (63.6) 20 (36.4) 56 (65.9) 29 (34.1) 2.0 2 0.360 2.0 1 0.158 0.1 1 0.805 
Item 3 21 (38.2) 34 (61.8) 31 (36.5) 54 (63.5) 0.4 2 0.825 0.3 1 0.608 0.1 1 0.728 
Item 4 10 (18.2) 45 (81.8) 12 (14.1) 73 (85.9) 59.1 2 0.0001 22.8 1 0.0001 36.3 1 0.0001 
Item 5 27 (49.1) 28 (50.9) 53 (62.4) 32 (37.6) 3.0 2 0.227 0.8 1 0.361 2.1 1 0.144 
Item 6 35 (63.6) 20 (36.4) 50 (58.8) 35 (41.2) 2.2 2 0.326 1.4 1 0.243 0.9 1 0.349 
Item 7 45 (81.8) 10 (18.2) 71 (83.5) 14 (16.5) 0.5 2 0.779 0.4 1 0.503 0.1 1 0.822 
Item 8 30 (54.5) 25 (45.5) 47 (55.3) 38 (44.7) 0.0 2 0.996 0.0 1 0.934 0.0 1 0.965 
Item 9 23 (41.8) 32 (58.2) 42 (49.4) 43 (50.6) 0.8 2 0.686 0.1 1 0.778 0.7 1 0.412 
Item 10 51 (92.7) 4 (7.3) 76 (89.4) 9 (10.6) 38.0 2 0.0001 36.7 1 0.0001 1.3 1 0.262 
Item 11 53 (96.4) 2 (3.6) 77 (90.6) 8 (9.4) 9.8 2 0.008 0.5 1 0.486 9.3 1 0.002 
 




Table 4-14. Item parameter estimates for different gender groups 
Items Male  Female 
a SE c SE  a SE c  SE 
To handle the medication-related problem identified, did you…          
Item 1: Entirely stop using the medication? 0.94 0.40 -0.29 0.30  2.00 0.57 -0.29 0.35 
Item 2: Seek out information that would help you resolve the problem? 1.48 0.60 -0.76 0.53  0.56 0.26 -0.69 0.24 
Item 3: Discuss the problem with your family or friends? 1.29 0.52 0.65 0.35  0.97 0.34 0.72 0.28 
Item 4: Discuss the problem with your healthcare provider? 1.67 0.78 2.19 0.61  33.00 6.54 40.88 4.99 
Item 5: Ask your physician or nurse to prescribe a different medication? 2.08 0.77 0.08 0.53  3.23 0.99 -1.13 0.53 
Item 6: Limit your activities or change your daily routines? 2.20 1.04 -0.93 0.52  0.93 0.29 -0.40 0.25 
Item 7: Take sick time or work less than usual? 4.17 2.67 -3.96 1.94  2.29 0.81 -2.92 0.70 
Item 8: Get another medication or home remedy to treat the problem? 0.99 0.42 -0.21 0.30  1.04 0.32 -0.23 0.25 
Item 9: Visit your healthcare provider to resolve the problem? 2.87 1.44 0.71 0.53  2.41 0.74 0.15 0.38 
Item 10: Visit an emergency department or go to urgent care? 28.16 4.06 -40.98 15.08  2.66 1.11 -4.18 1.15 
Item 11: Get admitted to the hospital? 24.94 21.07 -44.90 8.22  9.97 3.89 -14.11 5.56 
a: discrimination parameter, c: - a*b (b: difficulty parameter). 
 




Table 4-15. Education differential item functioning (DIF) statistics 









Item 1 37 (52.1) 34 (47.9) 39 (59.1) 27 (40.9) 1.0 2 0.598 1.0 1 0.322 0.0 1 0.827 
Item 2 52 (73.2) 19 (26.8) 37 (56.1) 29 (43.9) 4.6 2 0.099 0.0 1 0.974 4.6 1 0.032 
Item 3 29 (40.8) 42 (59.2) 23 (34.8) 43 (65.2) 1.6 2 0.458 0.0 1 0.862 1.5 1 0.217 
Item 4 9 (12.7) 62 (87.3) 13 (19.7) 53 (80.3) 0.6 2 0.727 0.5 1 0.471 0.1 1 0.732 
Item 5 39 (54.9) 32 (45.1) 40 (60.6) 26 (39.4) 0.1 2 0.963 0.1 1 0.813 0.0 1 0.888 
Item 6 40 (56.3) 31 (43.7) 43 (65.2) 23 (34.8) 0.2 2 0.926 0.1 1 0.795 0.1 1 0.769 
Item 7 58 (81.7) 13 (18.3) 55 (83.3) 11 (16.7) 0.4 2 0.838 0.2 1 0.657 0.2 1 0.694 
Item 8 38 (53.5) 33 (46.5) 39 (59.1) 27 (40.9) 1.0 2 0.615 1.0 1 0.324 0.0 1 0.986 
Item 9 29 (40.8) 42 (59.2) 35 (53.0) 31 (47.0) 2.5 2 0.291 2.4 1 0.119 0.0 1 0.858 
Item 10 62 (87.3) 9 (12.7) 62 (93.9) 4 (6.1) 57.7 2 0.0001 11.7 1 0.0006 46.0 1 0.0001 
Item 11 63 (88.7) 8 (11.3) 64 (97.0) 2 (3.0) 5.8 2 0.056 5.6 1 0.019 0.2 1 0.651 
 




Table 4-16. Item parameter estimates for different education level groups 
Items Some college or lower  College grad or higher 
a SE c SE  a SE c  SE 
To handle the medication-related problem identified, did you…          
Item 1: Entirely stop using the medication? 1.18 0.40 -0.10 0.31  1.99 0.72 -0.09 0.66 
Item 2: Seek out information that would help you resolve the problem? 1.13 0.42 -1.25 0.36  1.15 0.52 -0.02 0.46 
Item 3: Discuss the problem with your family or friends? 1.23 0.44 0.49 0.32  1.12 0.47 1.05 0.42 
Item 4: Discuss the problem with your healthcare provider? 1.78 1.28 2.83 1.15  6.41 6.30 6.97 6.53 
Item 5: Ask your physician or nurse to prescribe a different medication? 2.86 1.25 -0.35 0.58  2.50 0.84 -0.17 0.73 
Item 6: Limit your activities or change your daily routines? 1.40 0.57 -0.33 0.38  1.21 0.50 -0.49 0.47 
Item 7: Take sick time or work less than usual? 3.50 2.16 -3.55 2.14  2.41 1.13 -2.18 0.91 
Item 8: Get another medication or home remedy to treat the problem? 0.91 0.36 -0.16 0.29  1.53 0.51 -0.13 0.50 
Item 9: Visit your healthcare provider to resolve the problem? 12.36 6.28 3.20 2.86  2.44 0.86 0.39 0.68 
Item 10: Visit an emergency department or go to urgent care? 3.18 1.75 -4.20 1.83  32.73 8.46 -39.53 4.29 
Item 11: Get admitted to the hospital? 11.46 3.47 -14.30 4.60  2.37 1.69 -4.79 2.15 
a: discrimination parameter, c: - a*b (b: difficulty parameter). 
 





Table 4-17. Age differential item functioning (DIF) statistics 









Item 1 33 (51.6) 31 (48.4) 45 (59.2) 31 (40.8) 0.3 2 0.882 0.0 1 0.834 0.2 1 0.649 
Item 2 43 (67.2) 21 (32.8) 48 (63.2) 28 (36.8) 0.7 2 0.723 0.1 1 0.771 0.6 1 0.452 
Item 3 22 (34.4) 42 (65.6) 30 (39.5) 46 (60.5) 0.0 2 0.981 0.0 1 0.925 0.0 1 0.864 
Item 4 9 (14.1) 55 (85.9) 13 (17.1) 63 (82.9) 10.0 2 0.007 9.1 1 0.003 0.9 1 0.340 
Item 5 36 (56.3) 28 (43.8) 44 (57.9) 32 (42.1) 0.5 2 0.769 0.5 1 0.498 0.1 1 0.798 
Item 6 33 (51.6) 31 (48.4) 52 (68.4) 24 (31.6) 3.8 2 0.153 2.2 1 0.142 1.6 1 0.207 
Item 7 51 (79.7) 13 (20.3) 65 (85.5) 11 (14.5) 0.3 2 0.862 0.1 1 0.802 0.2 1 0.630 
Item 8 32 (50.0) 32 (50.0) 45 (59.2) 31 (40.8) 0.6 2 0.751 0.1 1 0.792 0.5 1 0.478 
Item 9 31 (48.4) 33 (51.6) 34 (44.7) 42 (55.3) 0.9 2 0.639 0.6 1 0.455 0.3 1 0.562 
Item 10 57 (89.1) 7 (10.9) 70 (92.1) 6 (7.9) 0.1 2 0.957 0.0 1 0.843 0.0 1 0.826 
Item 11 60 (93.8) 4 (6.3) 70 (92.1) 6 (7.9) 0.3 2 0.875 0.0 1 0.932 0.3 1 0.610 
 





Table 4-18. Item parameter estimates for different age groups 
Items Age < 57  Age ≥ 57 
a SE c  SE  a SE c  SE 
To handle the medication-related problem identified, did you…          
Item 1: Entirely stop using the medication? 1.43 0.55 -0.08 0.38  1.29 0.44 -0.30 0.34 
Item 2: Seek out information that would help you resolve the problem? 0.79 0.37 -0.81 0.32  0.93 0.33 -0.50 0.29 
Item 3: Discuss the problem with your family or friends? 1.06 0.48 0.80 0.35  1.01 0.35 0.71 0.35 
Item 4: Discuss the problem with your healthcare provider? 18.14 5.36 19.60 5.83  1.86 0.69 2.88 0.76 
Item 5: Ask your physician or nurse to prescribe a different medication? 2.12 0.80 -0.41 0.54  3.07 1.14 -0.24 0.65 
Item 6: Limit your activities or change your daily routines? 0.83 0.35 -0.07 0.30  1.82 0.57 -0.96 0.49 
Item 7: Take sick time or work less than usual? 2.44 0.99 -2.50 0.92  3.32 3.35 -3.78 3.19 
Item 8: Get another medication or home remedy to treat the problem? 1.07 0.41 0.01 0.34  0.93 0.32 -0.30 0.28 
Item 9: Visit your healthcare provider to resolve the problem? 2.21 0.84 0.13 0.55  5.47 4.28 1.78 1.65 
Item 10: Visit an emergency department or go to urgent care? 6.18 16.96 -7.96 18.95  2.81 1.29 -4.63 1.36 
Item 11: Get admitted to the hospital? 3.88 3.23 -6.62 4.15  4.44 5.70 -6.66 7.67 
a: discrimination parameter, c: - a*b (b: difficulty parameter). 
 





Table 4-19. Health literacy level differential item functioning (DIF) statistics 
 









Item 1 12 (44.4) 15 (55.6) 63 (57.8) 46 (42.2) 6.0 2 0.050 4.8 1 0.028 1.2 1 0.279 
Item 2 21 (77.8) 6 (22.2) 67 (61.5) 42 (38.5) 1.6 2 0.447 0.2 1 0.661 1.4 1 0.234 
Item 3 12 (44.4) 15 (55.6)  40 (36.7) 69 (63.3) 0.1 2 0.965 0.0 1 0.859 0.0 1 0.844 
Item 4 4 (14.8) 23 (85.2) 17 (15.6) 92 (84.4) 2.0 2 0.373 1.7 1 0.187 0.2 1 0.631 
Item 5 18 (66.7) 9 (33.3)  60 (55.0) 49 (45.0) 1.6 2 0.452 1.5 1 0.218 0.1 1 0.798 
Item 6 17 (63.0) 10 (37.0)  65 (59.6) 44 (40.4) 17.0 2 0.0002 16.1 1 0.0001 1.0 1 0.327 
Item 7 24 (88.9) 3 (11.1)  88 (80.7) 21 (19.3) 19.5 2 0.0001 10.4 1 0.001 9.1 1 0.003 
Item 8 12 (44.4) 15 (55.6)  64 (58.7) 45 (41.3) 2.8 2 0.244 2.6 1 0.109 0.3 1 0.616 
Item 9 12 (44.4) 15 (55.6)  51 (46.8) 58 (53.2) 1.6 2 0.460 0.9 1 0.336 0.6 1 0.429 
Item 10 27 (100.0) 0 (0.0)  96 (88.1) 13 (11.9) - - - - - - - - - 
Item 11 26 (96.3) 1 (3.7) 100 (91.7) 9 (8.3) 0.2 2 0.928 0.0 1 0.950 0.1 1 0.702 
 




Table 4-20. Item parameter estimates for different health literacy level groups 
Items Low  High 
a SE c  SE  a SE c  SE 
To handle the medication-related problem identified, did you…          
Item 1: Entirely stop using the medication? -0.01 0.45 0.06 0.36  1.35 0.42 -0.88 0.44 
Item 2: Seek out information that would help you resolve the problem? 0.76 0.63 -1.38 0.53  0.47 0.17 -0.64 0.24 
Item 3: Discuss the problem with your family or friends? 0.94 0.66 0.55 0.47  0.82 0.23 0.63 0.29 
Item 4: Discuss the problem with your practitioner? 0.13 0.63 1.65 0.49  1.18 0.49 2.67 0.81 
Item 5: Ask your physician or nurse to prescribe a different medication? 0.77 0.58 -0.67 0.45  1.96 0.77 -0.91 0.61 
Item 6: Limit your activities or change your daily routines? 31.02 7.61 -10.87 7.54  0.50 0.16 -0.56 0.24 
Item 7: Take sick time or work less than usual? 14.52 3.99 -18.98 3.84  1.10 1.19 -1.99 1.14 
Item 8: Get another medication or home remedy to treat the problem? 0.06 0.43 0.33 0.36  1.10 0.49 -0.39 0.62 
Item 9: Visit your practitioner to resolve the problem? 9.41 7.73 1.15 3.35  1.83 1.45 0.53 1.12 
Item 10: Visit an emergency department or go to urgent care? - - - -  - - - - 
Item 11: Get admitted to the hospital? 18.91 13.01 -34.89 26.14  20.88 28.34 -43.55 17.45 
a: discrimination parameter, c: - a*b (b: difficulty parameter). 
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4.5  Construction of a short-form  
A short-form was constructed by considering both the content of items and their 
psychometric properties. First, the most informative seven items (items 1, 4, 5, 7, 9, 10, 
and 11) were selected solely from a measurement perspective. These items contributed 
approximately 85% of the whole information covered by the scale, indicating that they 
provided relatively greater utility to the scale. Next, items were selected by their content 
from a clinical perspective regardless of their measurement properties. Nine items (items 
1, 4, 5, 6, 7, 8, 9, 10, and 11), which could provide clinically important content, were 
selected. Because seven of the nine items were also included in the first selection, they 
were candidates to be included in the short-form. However, item 7 (“took sick time or 
worked less than usual”) seemed to be rather incongruous with the other six items in that 
only this item did not involve any medication or healthcare provider(s) as patients’ 
coping behaviors in its content. Therefore, this item was no longer considered, remaining 
six items final short-form. Items in this short-form covered the majority (about 79%) of 








4.6  Person scores and T-score metric 
Using a person’s response patterns, the coping scores were estimated in an IRT-
metric. Table 4-21 and Figure 4-14 show a distribution of the EAP estimates of person 
scores which ranged from -1.67 to 2.15 with a mean of 0 and SD of 0.91. Since normal 
distribution was used as a prior distribution, the estimated EAP scores were toward zero.   
To improve interpretations of the scores, the scores were transformed into a T-
score metric (mean = 50, SD = 10) using a person’s summed scores. Table 4-22 shows 
conversions from summed scores to T scores. Using the conversion table, a total score of 
6, for example, is converted to a T-score of 55 with a standard error of 4. Therefore, the 
95% confidence interval for this observed score ranges from 47.2 (= 55-1.96*4) to 62.8 
(= 55+1.96*4). From the converted T-scores, patients’ coping level can be compared to 
the reference group which is the calibration sample in this study. A patient with a coping 
Figure 4-13. Test information on the 11 item pool and the 6-item short-form 
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score of 60, for example, indicates that this patient coping level is one standard deviation 
higher than the mean of the calibration population. 
However, the converted T-scores may not be reliable because sample size in our 




















Table 4-21. Frequencies of the expected a posteriori (EAP) estimates of person scores 
 
Estimated coping scores ( ) 
 
Number of patients 
 < -2.0 0 
-2.0 ≤  < -1.5 8 
-1.5 ≤  < -1.0 12 
-1.0 ≤  < -0.5 27 
-0.5 ≤  < 0 24 
0 ≤  < 0.5 31 
0.5 ≤  < 1.0 21 
1.0 ≤  < 1.5 11 
1.5 ≤  < 2.0 5 
2.0 ≤  < 2.5 1 
2.5 ≤  0 
 











Table 4-22. Summed score to scale score conversion table* 
Summed score Scaled score (T) Standard error 
0 33 6 
1 39 5 
2 43 5 
3 46 4 
4 49 4 
5 52 4 
6 55 4 
7 58 4 
8 61 4 
9 64 4 
10 68 4 
11 72 5 
* Scale scores are on a T-score scale. The values of standard deviation are reported as conditional standard error 
of measurement.  
Figure 4-14. Distribution of the expected a posteriori (EAP) estimates of person scores 
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4.7  Relationship between medication-problem coping scale and other 
constructs 
Correlations between this coping scale and other constructs were examined to 
assess convergent validity. First, as predicted, the coping scale was significantly 
correlated in a positive direction with problem scale (r = 0.646, p < 0.000). The mean 
coping scores for each group were shown in Table 4-23 and Figure 4-15. They suggest 
that coping scores (θ) were significantly higher in patients who perceived their problem 
as being larger. That is, patients reporting their ADP as large showed higher coping 
scores than those who perceived their ADP as small.  
Before evaluating the correlations between the coping level and health literacy 
level, a patient’s coping score (θ) was transformed into an exponential form (i.e., exp(θ)) 
because the homoscedasticity assumption was violated for the raw θ scores. Therefore, 
the correlations between them were appraised after this assumption was met with the 
transformed exponential scores. Results showed that patients with a high level of health 
literacy did not possess a significantly high coping level (r = 0.127, p = 0.141). To 
examine correlations between the exponential coping scores and health literacy levels in 
more detail, their relationships were graphically investigated (Figure 4-16). To 
investigate whether patients’ information seeking behavior is associated with their health 
literacy level, we compared patients’ health literacy levels between patients who sought 
out information and those who did not. As expected, health literacy levels for patients 
who sought out information to resolve their ADP were significantly higher compared to 
those who did not (X2 (4, N = 136) = 10.51, p = 0.033). This indicates that individuals 
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with higher confidence for their health literacy are more likely to seek out information as 
a way of handling their ADP.  
 
Figure 4-15. Mean coping scores for different problem intensity groups 
Table 4-23. Mean coping scores for different problem intensity groups 
Problem Scale N Mean coping score 
Very small 10 -1.038 
Small 27 -0.499 
Moderate 44 -0.312 
Big 32 0.366 
Very big 27 0.955 
Total 140 0 
 














Figure 4-16. Relationships between coping scores and health literacy levels 
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Finally, relationships between the coping scale and coping self-efficacy were 
investigated as shown in the Figure 4-17. Although positive correlation between patients’ 
coping self-efficacy and coping levels (θ) was hypothesized, this correlation was 
unexpectedly very weak (r = 0.029, p = 0.744). That is, patients’ ADP-coping levels were 
not or little correlated with their levels of coping self-efficacy. However, we observed the 
presence of ceiling effects (i.e., substantial scores were at or near the highest possible 
score) in our sample. Because of ceiling effects, only partial information about the scores 
of patients scoring at the ceiling was available, which might limit the ability to 
distinguish true differences between patients scoring at the highest in the CSE scale. 
Alternatively, patients may cope with their ADP using a different mechanism as they do 
when facing other general problems. Because coping self-efficacy was measured for 
handling general problems and not specific to adverse drug problems, patients’ coping 
levels in response to their ADP were not necessarily related to their levels of coping self-
efficacy. In other words, patient’s coping may be very specific to the characteristics of 
task or situation.   
   
92 
 
Figure 4-17. Relationships between the coping scale and coping self-efficacy 
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Chapter 5 : DISCUSSION 
5.1  Summary of study results 
The present study developed a medication-problem coping scale to measure 
patients’ coping responses to their perceived ADP using item response theory. The 
developed scale is brief and easy to administer for clinicians to receive patients’ 
immediate feedback on their coping behaviors. Patients’ coping behaviors would be 
measured precisely by applying items with good discriminating abilities and varying 
difficulty levels.  
Results of model comparison showed that the 2PL model was favored over 1PL 
based on its better fit to the item response patterns, more reliable θ score estimates, and 
less standard error of measurement over the coping continuum. The final 11-item pool, 
which was calibrated using the 2PL model, demonstrated adequate psychometric 
properties including unidimensionality, local independence, and acceptable fit statistics. 
DIF was examined for items in the final pool between patients who perceive the 
problem intensity differently and between different groups in demographics and health 
literacy levels. Items with significant X2 results stemmed from their unreliable 
parameter estimates due to very few observations in the response categories rather than 
their differential functioning for different groups. For these items, DIF should be 
reexamined with a much larger sample to obtain reliable parameter estimates for these 
items that are infrequently endorsed.  
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 The coping scores were computed based on IRT response patterns using a 
Bayesian approach, an expected a posterior (EAP) method. Alternatively, the overall 
coping scores were obtained by summing individual item scores to convert the summed 
scores to T-scores. Using such norm-based scores, an individual’s coping level can be 
quickly and conveniently interpreted. However, a further study with large sample size in 
diverse clinical settings is recommended to produce more stabilized respondents’ scores 
and T-scores. This will allow comparison of patients’ coping status with a more global 
reference group (e.g., the general clinical population) than the calibration sample in this 
study.   
 A short-form was constructed with six items selected based on their amount of 
information and content representation. All items in the short-form exhibited high or 
very high discrimination parameter estimates. This 6-item short-form provided the 
majority of the test information, suggesting its comprehensive coverage along the 
coping trait continuum. The short-form will be used to reduce patients’ burden and save 
clinicians’ time in various settings. However, if it is required to measure a coping trait 
more precisely, the whole 11-item pool should be administered to produce a more 
precise score.  
Convergent validity was assessed by testing a priori hypotheses about expected 
correlations between the coping levels and other related measures. First, coping levels 
(θ scores) were compared between groups who perceived their problem intensity 
differently. As expected, respondents reporting their ADP as relatively large had rather 
higher coping levels compared with those who perceived their ADP as small, 
supporting convergent validity. These findings broadly suggest that the medication 
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problem coping item banks are able to detect changes in perceived problem intensity. 
Contrary to expectations, patients’ coping levels were not significantly correlated with 
their health literacy levels. However, health literacy levels were higher in patients who 
sought out information as a coping behavior than those who did not. This indicates 
associations particularly between critical health literacy and information-seeking 
behavior as a way of coping. Because of the critical literacy component, which was 
defined as high level of cognitive and social skills required to access, understand, and 
evaluate information on the determinants of health, and to use this information to 
control situations (WHO), health literacy has expanded its conceptual meaning to 
include information-seeking, along with a multitude of other imperative abilities and 
skills to make health-related decisions. Our results empirically supported this 
conceptualization of health literacy.  
Finally, there was unexpectedly little or no relationship between patients’ coping 
levels and their coping self-efficacy. However, ceiling effects should be noted when 
interpreting this result. The true relationship between them might be weakened because 
of the limited ability to distinguish true differences between patients scoring at the 
highest levels in the CSE scale. Using all six items rather than three items of the 
problem-focused CSE scale might overcome this problem. Alternatively, there might be 
little or no relationship between them aside from ceiling effects. That is, a patient’s 
coping level was not necessarily high even though their coping self-efficacy for 
handling the general problems was high. This suggests that patients’ coping seemed to 
vary depending on the situations. For example, when a patient faces a medication-
related problem as this study, the patient may think that this situation requires 
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practitioner’s interventions and less actively cope with this problem even though their 
coping self-efficacy is high. This is a different situation compared to several cases 
shown in the previous studies where patients can control the problems on their own by 
changing their behaviors such as a smoking cessation, weight control, or use of 
contraception. For this reason, the importance of understanding an encountered specific 
situation should be noted in assessing an individual’s coping. As Maes et al. stated in a 
review of coping with chronic illness, “only studies that take into account 
characteristics of the stressor can lead to a full understanding or the coping process and 
its success” (Zeidner & Endler, 1996) .  
 
5.2  Study limitations 
Several limitations of this study should be noted. First, the use of a non-
probability sample collected only from the community pharmacies and small sample 
size limits the degree to which study results can be generalized. It is not certain how 
much respondents in this study perceive ADPs and respond to them differently 
compared to patients in other clinical setting (e.g., hospital or nursing facility). Patients 
where their access to practitioners is easily made may answer differently to the 
questionnaire. They might more frequently endorse the items that involve an interaction 
with practitioners as a coping strategy compared to this study sample. This would result 
in different parameter estimates for such items. In addition, parameters in IRT are 
estimated more accurately with large sample sizes. With small sample sizes, a simple 
model which allows only a difficulty parameter to vary (e.g., 1PL) is known to be 
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adequate. For example, Linacre suggested a sample size of more than 30 or 50 for the 
simple Rasch model to be 95% or 99% confident that no item parameter is more than 1 
logit from its stable value (Linacre, 1994). However, larger sample sizes are required as 
the model becomes complex with more parameter estimates. In this study with a sample 
size of 140, items fit the 2PL model better than the 1PL model. However, a future study 
with larger sample size can produce more stable parameter estimates. It also allows 
cross-validation with independent sets of data in model comparisons. Second, a 
causality assessment on the relationship between patients’ perceived ADPs and their 
coping was not conducted; thus, there is a possibility that the problems perceived by 
patients are incorrectly attributed to their medication use. They may in fact result from 
other causes, such as the disease itself or their diet. However, the ultimate purpose of 
this study is to identify health problems that patients perceive and to improve their 
medication management after communicating with clinician once patients are 
recognized as having ADPs. In this sense, the true unknown origin of the problems is 
not a big concern if this scale is used as intended. Finally, since only problem-focused 
coping was highlighted in a new measure, the suitability of this measure for patients 
who mostly employ emotion-focused coping is questionable. For example, this scale 
may not be applicable to patients with a high level of negative symptoms in 
schizophrenia who are known to use most emotion-related coping and less problem-
focused coping in response to stressors (Wiedl, 1992). Further study that includes items 
related to emotion-focused coping would enable investigation of this coping type in 
such population.  
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5.3  Strengths of study 
To my knowledge, this is the first study that developed a medication problem 
coping scale using item response theory (IRT). As a novel technique, this theory has 
gaining its prominence in the development and evaluation of a variety of health-related 
measures. The scale developers take advantages of using IRT because it provides more 
precise measures with fewer items, and improves efficiency by minimizing the number 
of items required to obtain a desired degree of precision. Therefore, in this study, a scale 
was developed using IRT to provide more precise measures across the full spectrum of 
patients’ coping ranges, with less respondent burden. In addition, patients’ coping with 
perceived ADP is measured based on the patients’ perspectives. Over the past 40 years, 
the paradigm in healthcare has shifted, placing patients from passive recipients of 
treatment to active players in the process of care. In the new paradigm, the influence of 
patients’ perspectives in health-related decisions has grown in importance. This change 
notwithstanding, patients’ experience of ADPs has been evaluated from the clinicians’ 
perspective to date. Notably, there is a considerable discrepancy between patients’ 
perceived ADPs and physicians’ evaluations of ADPs. In addition, clinicians may not 
even be aware of the patients’ perceived ADPs. Using a newly developed scale, patients 
can report their coping strategies when they perceive ADPs. This is the most precise 
way of measuring them, particularly when patients’ self-reports do not correspond to 
those drawn from clinical measures. The outcome of this study is the practical scale that 
clinicians can use in their patient population to receive patients’ immediate feedback on 
their coping with perceived ADP. In particular, it can serve as a screening device for 
further formal assessment of ADPs and a guidance to develop a future intervention. 
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Clinicians will be able to provide appropriated interventions tailored to the individual 
who suffer from an ADP. After receiving practitioners’ assistance on the ADP, patients 
are able to achieve safe medication use by improving ADP management. 
 
5.4  Future research 
Future research will involve further validation of the MPCS item banks. Validity 
can be evaluated by comparing information about a patient’s responses to ADPs 
obtained from the patient’s medical records (e.g., whether a patient discontinued the 
ADP-related medication, discussed the ADP with a healthcare provider, asked a 
healthcare provider to prescribe a different medication due to the ADP, visited a 
healthcare provider to resolve the ADP, visited an emergency department or urgent 
care, or was hospitalized) with such information from MPCS. Consensus between them 
made by experts will support validity. If validity of the MPCS is evidenced, its utility, 
as a screening device or a case identification tool, can be investigated in clinical 
settings. The MPCS was developed to suggest a coping level that was associated with 
the ADP intensity. This implies that patients with a high coping level are more likely to 
perceive their ADP as large. Therefore, healthcare providers can have opportunities to 
provide interventions to their patient with a high coping level using information from 
the MPCS. Such information includes whether the patient is still using the problem-
related medication, discussed the problem with a healthcare provider already, or went to 
a hospital to treat the problem. If a healthcare provider finds out that his or her patient 
who perceived the ADP as large still uses an ADP-related medication, the healthcare 
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provider can discuss about discontinuing and changing the medication with the patient. 
Alternatively, the healthcare provider can ask the details about the ADP that a patient 
experienced unless the patient has discussed it yet, and develop a next treatment plan.  
 
Conclusions 
State of the art IRT methods were employed to develop a reliable and valid 
medication-problem coping scale and its brief version (Appendix F and G). This new 
measure of how patients cope with ADPs warrants further research to establish its 
clinical utility. The final item bank and its short-form should be applied to large 
samples in diverse clinical settings to evaluate their usefulness. Further research is 
needed to test the validity and accuracy for identifying clinically significant adverse 
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Part I: Problems from Medication Use 
Screening questions:   
1. Have you used any prescribed medication(s) on a regular basis? 
 Yes                       No  If you will use the prescription(s) you are picking up today, may I 
call you if about a month to ask about any problem that is 
associated with medication use? 
 Yes (Phone #:                      )     No  Thank you! 
 
2. (If yes) How many medications do you take?   ________________________ 
3. In the last year, have you had any new medication-related problems or have any of your health problems become 
worse because of your medication(s)? 
 Yes                       No  Go to Part II 
 
(If yes) Please pick the most bothersome problem and describe it briefly. Which medication was the most 
associated with this problem?  
___________________________________________________________________________________ 
4. When you experienced the problem, how long did the problem last?    _________________________ 
5. How often have you experienced this problem while using this medication? 
_____________________________________________________________________________________ 
6. To what extent, was this a problem for you?  
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To handle the medication-related problem identified in the previous question #3, did you…  
1. Entirely stop using the medication?           Yes   No 
2. Continue to use the medication as prescribed in spite of the problem?     Yes   No 
3. Use the medication less frequently?          Yes   No 
4. Reduce the dose of the medication?          Yes   No 
5. Use a non-prescription medication instead of using the medication?       Yes   No 
6. Use home remedy instead of using the medication?        Yes   No 
7. Search for written information about the problem (on the internet, in a book, etc)?    Yes   No 
8. Try to learn more about if the problem is related to your medication?     Yes   No 
9. Try to see if other people like you experienced the same problem you had?     Yes   No 
10. Seek out information that would help you resolve the problem?      Yes   No 
11. Discuss the problem with your family or friends?         Yes   No 
12. Discuss the problem with your pharmacist?         Yes   No 
13. Discuss the problem with your physician or nurse?        Yes   No 
14. Ask your physician or nurse to prescribe a different medication?       Yes   No 
15. Limit your activities or change your daily routines?          Yes   No 
16. Take sick time or work less than usual?        Yes   No 
17. Get another prescription medication to treat the problem?       Yes   No 
18. Use a non-prescription medication to treat the problem?         Yes   No 
19. Use home remedy to treat the problem?         Yes   No 
20. Go to visit your pharmacist to resolve the problem?         Yes   No 
21. Go to visit your physician or nurse to resolve the problem?       Yes   No 
22. Visit an emergency department or go to urgent care?       Yes   No 
23. Get admitted to the hospital?          Yes   No 
24. How satisfied are you with how the medication problem was handled? 
 Very unsatisfied        Unsatisfied         Neither unsatisfied nor satisfied         Satisfied        Very satisfied 
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Part II: Information About you 
1. Gender:    Male                    Female 
2. Age:   ________________________              
3. Which best describes your race: 
 White       Native-Hawaiian or other Pacific Islander 
 Black or African-American     Hispanic or Latino 
 American Indian or Alaska Native    Other, describe: __________________________ 
 Asian 
4. Do you have somebody who lives with you to help you use your medication(s)?    Yes                    No 
5. What is your employment status? 
 Currently employed  
 Currently unemployed  
 Retired 
 Other, describe: __________________________ 
6. What is your highest level of education? 
 High School           
 Some college    
 College graduate 
 Post graduate 
7. Do you have a health insurance?   Yes                    No 
8. Do you have a healthcare background?    Yes                    No 
9. How confident are you filling out health forms by yourself? 
 Not at all       A little bit       Somewhat       Quite a bit       Extremely 
For each of the following items, write a number from 0 – 10, using the scale below. 
 
 
 | | | | | | | | | | | | | | | | | | | | |  
 0 1 2 3 4 5 6 7 8 9 10 
 
When things aren’t going well for you, how confident are you that you can:  
 
10. Sort out what can be changed, and what cannot be changed.                                                                _________            
11. Break an upsetting problem down into smaller parts.               _________    
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Appendix B. IRB application: Consent form 
 




Development of an instrument to assess patient’s coping responses to perceived adverse 
drug problems (ADPs) using item response theory (IRT) 
 
You are invited to be in a research study of experience of adverse drug problems (ADPs) 
and coping responses to such problems. You were selected as a possible participant 
because you have taken one or more medication(s), and experienced a health-related 
problem that you attribute to your medication use. We ask that you read this form and ask 
any questions you may have before agreeing to be in the study. 
This study is being conducted by Taehwan Park, PhD candidate, Social and 
Administrative Pharmacy at the University of Minnesota.  
 
Background Information 
The purpose of this study is to examine patients’ experience of a health-related problem 
after starting taking a medication and how they decide to handle such a problem. This 
study involves no medicines or invasive procedures. All participants will continue their 
usual medical care. We only ask a few basic questions about a health-related problem that 




If you agree to be in this study, you will receive a questionnaire which is expected to be 
completed. The questionnaire consists of a few basic questions asking about your 
experience of a health-related problem, and about twenty questions asking about 
frequency of what you did to cope with such a problem. That is, each question will show 
each possible coping behavior and you can check how often you actually behaved in that 
way among the five response categories (i.e., never, rarely, sometimes, often, and very 
often). It will not take longer than 10 minutes. If a question is not clear or the meaning of 
a question is not understandable, please feel free to ask me.  
 
Risks and Benefits of being in the Study 
There is no expected risk and benefit to you as a participant in this study. However, if 
you feel any discomfort or embarrassment for any reason while answering the question, 
you are free to deny answering it.   
 
Compensation: 




The records of this study will be kept private. In any sort of report we might publish, we 
will not include any information that will make it possible to identify a subject. Research 
records will be stored securely and only researchers will have access to the records. Study 
data will be encrypted according to current University policy for protection of 
confidentiality.  
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Voluntary Nature of the Study: 
Participation in this study is voluntary. Your decision whether or not to participate will 
not affect your current or future relations with the University of Minnesota. If you decide 
to participate, you are free to not answer any question or withdraw at any time without 
affecting those relationships.  
 
Contacts and Questions: 
Taehwan Park is the researcher responsible for conducting this study. You may ask any 
questions you have now. If you have questions later, you are encouraged to contact me 
at parkx672@umn.edu or (213) 200 0314. You may also contact my advisor, Dr. Ronald 
S Hadsall at hadsa001@umn.edu or (612) 626 9938.  
 
If you have any questions or concerns regarding this study and would like to talk to 
someone other than the researcher(s), you are encouraged to contact the Research 
Subjects’ Advocate Line, D528 Mayo, 420 Delaware St. Southeast, Minneapolis, 













































































Appendix C. IRB approval 
 





Subject: 1204E12567 - PI Park - IRB - Exempt Study Notification 
Date: Mon, 16 Apr 2012  
TO : hadsa001@umn.edu, parkx672@umn.edu, 
The IRB: Human Subjects Committee determined that the referenced study is exempt 
from review under federal guidelines 45 CFR Part 46.101(b) category #2 
SURVEYS/INTERVIEWS; STANDARDIZED EDUCATIONAL TESTS; 
OBSERVATION OF PUBLIC BEHAVIOR. 
  
Study Number: 1204E12567 
  
Principal Investigator: Taehwan Park 
  
Title(s): Development of an instrument to assess patient's coping responses to perceived 
adverse drug problems (ADPs) using item response theory (IRT) 
 
This e-mail confirmation is your official University of Minnesota RSPP notification of 
exemption from full committee review. You will not receive a hard copy or letter. This 
secure electronic notification between password protected authentications has been 
deemed by the University of Minnesota to constitute a legal signature. 
  
The study number above is assigned to your research.  That number and the title of your 
study must be used in all communication with the IRB office. 
Research that involves observation can be approved under this category without 
obtaining consent. 
  
SURVEY OR INTERVIEW RESEARCH APPROVED AS EXEMPT UNDER THIS 
CATEGORY IS LIMITED TO ADULT SUBJECTS. 
  
This exemption is valid for five years from the date of this correspondence and will be 
filed inactive at that time. You will receive a notification prior to inactivation. If this 
research will extend beyond five years, you must submit a new application to the IRB 
before the study’s expiration date. 
  
Upon receipt of this email, you may begin your research.  If you have questions, please 
call the IRB office at (612) 626-5654. 
You may go to the View Completed section of eResearch Central at 
http://eresearch.umn.edu/ to view further details on your study. 
  
The IRB wishes you success with this research. 
 
 
























Appendix D. Project introduction to Minnesota Pharmacy PBRN 
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To whom it may concern,  
You are invited to participate in a research study of patients’ experiences of adverse 
drug problems (ADPs) and coping responses to such problems. I am writing as the 
principal investigator of this research project from the University of Minnesota, and you 
were selected because your pharmacy is incorporated in the Minnesota practice-based 
research network (PBRN). Your participation is very much needed as we begin to 
collect data. Please read this over and let us know if you are able to participate in this 
study using contact information below. 
 
Study Information 
The purpose of this study is to examine patients’ experiences of ADP after taking 
medication and how they decide to handle such an identified problem. This study is 
based on a questionnaire/interview conducted by me (Taehwan Park), and involves no 
medicines or invasive procedures. We ask a few basic questions about an ADP that your 
patient’s experienced and attribute to their medication use. This study and the protocol 
have been approved by the University of Minnesota’s Institutional Review Board (IRB) 
(Study number: 1204E12567). 
  
Procedures: 
If you allow this study to be conducted in your pharmacy, your patients will be asked 
about their willingness to participate in this study. A patient is eligible if he or she has 
any health-related problem that they attribute to their medication use. If a patient agrees 
to be involved in this study, he or she will receive a questionnaire or participate in an 
interview. The questionnaire consists of a few basic questions asking about experiences 
with the health-related problem, and about twenty yes/no questions asking whether 
patients used each coping strategy. It will not take longer than 15 minutes per patient. I 
will assist each patient in answering the questions. There are no expected risks or 
benefits to the participants in this study, and they are free to choose not to participate in 
the study or answer any question during their participation.  
 
Time period of the Study: 
We will start to collect data from your patients contingent on your decision. It will 
continue until we can obtain 200 responses from the participating pharmacies 
incorporated in the Minnesota PBRN - including your pharmacy if you chose to 
participate. We do not anticipate data collection taking longer than 10 days in your 
pharmacy. Participation in this study is voluntary and you can withdraw your 
participation at any time. Your decision whether or not to participate will not affect 
your current or future relations with the University of Minnesota or the Minnesota 
PBRN. There is no compensation for or costs involved in participating in this study. 
However, we would like to acknowledge you in the dissertation or any future 
publication from the study as a token of our appreciation. A copy of results and tested 
instrument will be available upon your request.  
 
Contacts and Questions: 
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Taehwan Park is the researcher responsible for conducting this study under the guidance 
of his advisor, Ronald S Hadsall. If you have any question or want to see a copy of 
questionnaire or IRB approval prior to participation, please contact me at 
parkx672@umn.edu or (213) 200 0314 or my advisor at hadsa001@umn.edu or (612) 
626 9938. You may also contact a director of graduate studies, Dr. Jon C Schommer at 

















































Appendix E. Participant recruitment script 






Hello, my name is Taehwan Park and I am a graduate student at the University of 
Minnesota College of Pharmacy. I am doing a research project of investigating 
individual’s experience on drug-related problems. I’d like to know if you are willing to 
participate in this study. If you agree to participate, I will ask you to complete a 
questionnaire which consists of about twenty main questions. They are asking about 
your drug-related problem and how you handled it. This will take about 10 minutes at 
most. Would you be willing to participate? 
 
(If a subject does not want to participate,) Thank you. 
 
(If a subject agrees to participate,) Thank you very much for your participation. Now I 
will get you a questionnaire which you can complete. If any question is not clear or the 
meaning of a question is not understandable, please feel free to ask me. 
 







































Appendix F. Medication Problem Coping Scale (MPCS) Items 




MEDICATION PROBLEM COPING SCALE (MPCS) 
 
In the last year, have you had any side effect or have any of your health problems 
become worse because of your prescribed medication(s)?  
 No       Yes  
If “No”, you have completed this questionnaire. If “Yes”, please specify this problem 
you experienced and answer the following questions below. (If you have more than one 
































There are many different ways to deal with side effect problems. Here are some 
strategies that people use to handle such problems. Please indicate whether you used 
each strategy to hadle the problem you specified above. 
To handle the problem you identified, did you… 
1. entirely stop using the medication?  No         Yes 
2. seek out information that would help you resolve the problem?  No         Yes    
3. discuss the problem with your family of friends?   No         Yes                                     
4. discuss the problem with your healthcare provider?   No         Yes          
5. ask your physician or nurse to prescribe a different medication?   No         Yes 
6. limit your activities or change your daily routines?   No         Yes 
7. take sick time or work less than usual?   No         Yes 
8. get another medication or home remedy to treat the problem?   No         Yes 
9. visit your healthcare provider to resolve the problem?   No         Yes 
10. visit an emergency department or go to urgent care?   No         Yes 
11. get admitted to the hospital?          No         Yes 














































Appendix G. Brief Medication Problem Coping Scale (BMPCS) items  





BRIEF MEDICATION PROBLEM COPING SCALE (BMPCS) 
 
In the last year, have you had any side effect or have any of your health problems 
become worse because of your prescribed medication(s)?  
 No       Yes  
If “No”, you have completed this questionnaire. If “Yes”, please specify this problem 
you experienced and answer the following questions below. (If you have more than one 






























There are many different ways to deal with side effect problems. Here are some 
strategies that people use to handle such problems. Please indicate whether you used 
each strategy to hadle the problem you specified above. 
To handle the problem you identified, did you… 
1. entirely stop using the medication?  No         Yes 
2. discuss the problem with your healthcare provider?   No         Yes          
3. ask your physician or nurse to prescribe a different medication?   No         Yes 
4. visit your healthcare provider to resolve the problem?   No         Yes 
5. visit an emergency department or go to urgent care?   No         Yes 
6. get admitted to the hospital?          No         Yes 
